Reproductive biology is a uniquely important topic since it is about germ cells, which are central for transmitting genetic information from generation to generation. In this review, we discuss recent advances in mammalian germ cell development, including preimplantation development, fetal germ cell development and postnatal development of oocytes and sperm. We also discuss the etiologies of female and male infertility and describe the emerging technologies for studying reproductive biology such as gene editing and single-cell technologies.
Introduction
Reproductive biology concerns the development of the oocyte and the sperm from the fetal germ cell (FGC), the development of the FGC from the preimplantation and implantation embryo, as well as the production of a zygote from the fusion of an oocyte and a sperm, which make a complete germline cell cycle. Novel technologies such as the single-cell sequencing and gene editing bring new opportunities for deeply understanding this cycle. The current studies are also shedding light on the female and male infertility, which affects 10%-15% of couples of reproductive ages. In this review, we will discuss recent progress on reproductive developmental biology and diseases. In the first part, we will discuss the development of preimplantation embryos, FGCs, oocytes and sperms. In the second part, we will discuss the etiologies of female and male infertility. In the last part, we will discuss the emerging technologies for studying reproductive biology including the gene editing technologies and the single-cell spatially resolved transcriptomics.
Reproductive developmental biology

Preimplantation development
The development of a multicellular organism from a singlecell zygote, which is produced by the fusion of a terminally differentiated oocyte and sperm, is a highly complex process. In mammals, embryonic development and the associated molecular regulatory mechanisms are generally conserved. Once fertilized, the zygote divides several times to form a compact morula and further develops into a blastocyst. When the zonapellucida around the blastocyst disappears, the blastocyst starts to implant into the uterine wall and develop into a trilaminar embryo with ectoderm, endoderm and mesoderm layers through gastrulation. These three layers will subsequently produce many structures at different developmental stages. The endoderm, the innermost germ layer, contributes to the lining of tubular organs (the gastrointestinal tract, respiratory tract, etc.) and other internal organs (the liver, pancreas, etc.). The mesoderm, the middle germ layer, contributes to muscle as well as the skeletal and circulatory systems. The ectoderm, the outermost germ layer, contributes to the brain, the nervous system, and the skin and other external tissues. After gastrulation, the embryo develops through critical and well-conserved events, such as somitogenesis, neurulation and organogenesis, and ultimately becomes a fully functional organism with the ability to survive independently. On average, the development of a mouse embryo takes 19 days from fertilization to birth, while a human embryo takes approximately 40 weeks to develop.
Maternal-to-zygotic transition (MZT)
Usually, both mature oocytes and sperm are transcriptionally silent. Initially, the fertilized zygote is also in a transcriptionally quiescent state. Maternally deposited mRNAs, ribosomes, transfer RNAs (tRNAs) and proteins are crucial for the first stage of embryonic development. Subsequently, the zygotic genome becomes active, and the cells are reprogrammed into a totipotent state. This switch is called the MZT. During the MZT, complex cellular events occur, including maternal product degradation, zygotic genome activation (ZGA), and global chromatin remodeling (Lee, 2017; Marco, 2017; Tadros and Lipshitz, 2009) .
Previous studies have shown that the RNA-binding protein Smaug (SMG) (Dahanukar et al., 1999) , AU-rich element (ARE)-binding proteins (De Renzis et al., 2007) and mi-croRNAs (miRNAs) (Giraldez et al., 2006) play important roles in maternal transcript degradation. However, the exact function of maternal clearance and the molecular control mechanisms in mammals require further investigation.
The timing of ZGA varies widely across different vertebrate species. In most mammalian species, ZGA occurs with minor and major transcription waves. After fertilization in mice, transcription is first detectable at low levels in the male pronucleus, even when the male and female pronuclei remain separate in the zygotic G2 phase (Hamatani et al., 2004) . The major wave of transcription occurs at the late 2-cell stage. In humans, low levels of transcription occur in the zygote until the 4-cell stage (Xue et al., 2013) , and the major wave of transcription takes place at the 8-cell stage (Vassena et al., 2011) . Protein-coding transcripts as well as noncoding RNAs (ncRNAs), including small nucleolar RNAs (snoRNAs), long ncRNAs (lncRNAs), and repeat and transposon elements, are all transcribed in transcription bursts (Friedli and Trono, 2015; Svoboda, 2017) . All transcripts may play important regulatory roles in development. ZGA is critical for embryogenesis. If transcription is inhibited, embryonic development will be arrested because of developmental defects. Mouse embryo arrest occurs at the 2-cell stage (Hamatani et al., 2004) , and human embryo arrest occurs at the 8-cell stage. Three broad models help explain the ZGA timing (Jukam et al., 2017; Lee et al., 2014b ). The first model involves the nucleo-cytoplasmic (N/C) ratio. In early division cycles, the volume of cytoplasm within the embryo remains constant, while the nuclear content and the nuclear volume increase. In this model, N/C ratio elevation results in titration of maternally deposited transcriptional repressors. The second model is the maternal clock model, which specifies that after fertilization, maternal products initiate a biochemical cascade. For example, transcriptional activators increase in quantity or activity until they reach a critical level to trigger transcription. The third model posits de novo establishment of chromatin states. These models are not mutually exclusive but rather may coexist and cooperate to regulate ZGA.
Chromatin remodeling during preimplantation development Shortly after fertilization, chromatin remodeling occurs in parental nuclei, which involves histone incorporation, genome-wide DNA demethylation and remethylation, histone modification, gradual establishment of open chromatin patterns, and changes in three-dimensional (3D) chromatin conformations.
After mammalian spermatogenesis, mature sperm chromatin is highly condensed and bound by arginine-rich protamines (Rathke et al., 2014) . Histones cover only ∼2%-4% of the sperm genome in mice (Carone et al., 2014) and 10%-15% of the sperm genome in humans (Oliva, 2006) . Soon after fertilization, maternally supplied histones displace protamines on the paternal genome, and the chromatin is repackaged (Oliva, 2006; Rodman et al., 1981; Torres-Padilla et al., 2006) .
In mammals, the cytosine in cytosine-phosphate-guanine (CpG) dinucleotides is usually methylated by DNA methyltransferases (DNMTs) at the fifth carbon (5mC) (Okano et al., 1999; Ziller et al., 2011) . DNA methylation is involved in many transcriptional silencing-associated processes, such as genomic imprinting, X chromosome inactivation and regulation of retrotransposon repression (Ci and Liu, 2015; Li, 2002; Smith and Meissner, 2013) . In mice, sperms exhibit high levels of DNA methylation, while oocytes exhibit intermediate levels (Smallwood et al., 2011) . After fertilization, parental nuclei undergo genome-wide demethylation, and the methylation patterns are reestablished during gastrulation Wang et al., 2014a) . Significant demethylation occurs at most functional genomic elements, such as promoters, exons, introns and 3′ untranslated regions (UTRs) (Wang et al., 2014a ). An analysis of allele-specific and whole-genome mouse DNA methylation revealed that the paternal methylome and at least a significant proportion of the maternal methylome are actively demethylated during embryonic development (Wang et al., 2014a) . DNA methylation reprogramming during preimplantation embryonic development is rather conserved among mice and humans, although human embryos undergo a major wave of demethylation at the 2-cell stage Smith et al., 2014) . It has been reported that abnormal genome-wide methylation reprogramming occurs in human blastocysts . Whether this abnormal reprogramming can lead to miscarriage needs clinical verification.
DNA is packaged and ordered into structural units called nucleosomes, each of which contains a core octamer of histone proteins. The histones in the octamer are often covalently and posttranslationally modified through such processes as methylation and acetylation. These histone modifications affect gene transcription by changing the chromatin structure or by affecting the loading of transcription factors. Profiling of genome-wide histone modifications in early embryos has become achievable with therapeutic advances in low-input chromatin immunoprecipitation (ChIP) sequencing (ChIP-seq) (Dahl et al., 2016; Liu et al., 2016; Wang et al., 2018a; Zhang et al., 2016; Zheng et al., 2016) . Trimethylation (me3) of lysine (K) 4 on histone H3 (H3K4me3) is usually associated with active promoters in somatic cells. H3K4me3 modifications typically present as sharp peaks at transcription start sites (TSSs). Mature mouse oocytes exhibit unique and unusual patterns with large domains of H3K4me3 spanning more than 10 kb, covering approximately 22% of the oocyte genome . These domains are established gradually in oogenesis and are negatively correlated with large DNA methylation domains. The broad H3K4me3 domains can also be observed in zygotes and early two-cell embryos, but they are largely absent in later stages, when the patterns become canonical at TSS regions (Dahl et al., 2016; Liu et al., 2016; Zhang et al., 2016) . The establishment and removal of broad H3K4me3 domains are important for oocyte genomic silencing and normal embryonic development. In general, broad H3K4me3 domains are generally distant from the TSS. In 2-cell-stage embryos, the numbers of H3K4me3-marked promoters increase quickly, and most of the promoters will retain this modification in later stages. In contrast to H3K4me3, H3K27me3 is usually associated with inactive promoters in somatic cells. Similar to H3K4me3, however, the repressive marker H3K27me3 is also present in broad domains in second meiotic metaphase (MII) oocytes and 2-cell embryos, even in the embryonic day (E) 3.5 inner cell mass (ICM), while the patterns switch to canonical forms in postimplantation embryos Zheng et al., 2016) . However, the broad H3K27me3 domains overlap with the broad H3K4me3 domains, and in contrast to H3K4me3, H3K27me3 peaks mark promoters only in oocytes, disappearing before the major ZGA. H3K27me3 in promoters is not correlated with DNA methylation levels, indicating that the establishment mechanisms of H3K4me3 and H3K27me3 are different. In preimplantation embryos, H3K27me3 is not enriched at the promoters of most canonical Polycomb targets. Acetylation (ac) of K27 on histone H3 (H3K27ac) is usually associated with active enhancers. The levels of H3K27ac are higher in two-cell embryos than in oocytes. In the 2-cell and 8-cell stages, H3K27ac marks the TSS-containing domains of ZGA genes, indicating the relationship between H3K27ac and transcriptional activity. H3K9me3 is a marker for constitutive heterochromatin. In mouse preimplantation embryos, H3K9me3 is enriched at long terminal repeats (LTRs) but not in promoters, unlike H3K4me3 and H3K27me3 . The number of H3K9me3 domains increases dramatically in the 2-cell stage. Most paternal and maternal H3K9me3 regions are established de novo after fertilization, and the imbalance of H3K9me3 signals between the paternal and maternal genomes lasts throughout early embryonic development until the blastocyst stage. Lineage-specific H3K9me3-marked promoters are established in postimplantation embryos.
Chromatin accessibility reflects the occupancy of the genome by DNA-binding proteins, such as transcription factors. Recent advances in low-input chromatin accessibility assays, such as DNase I hypersensitivity sequencing (DHS-seq) and the assay for transposase-accessible chromatin sequencing (ATAC-seq), have revealed that the accessible chromatin landscape undergoes reorganization during the MZT in mammals Lu et al., 2016; Wu et al., 2016; Wu et al., 2018) . Fewer DHS sites are detected in zygotes than in embryos of other stages, and most DHS sites are located at promoter regions. In mouse early 2cell embryos, when minor ZGA is active but before major ZGA, the ATAC-seq signal is weak and noisy . A large fraction of the weak peaks is located at or close to (<100 kb from) minor ZGA genes, such as mouse MERVL genes. This proximity is consistent with the particularly promiscuous transcription of minor ZGA genes. At the 8-cell stage in humans, distal peaks of accessible chromatin are also enriched for repeats such as Alus, SINE-VNTR-Alus (SVAs), K-type human endogenous retroviral elements (HERV-Ks) and H-type human endogenous retroviral elements (HERV-Hs), which is coordinated with the expression of these regions in preimplantation embryos . At the late 2-cell stage in mice, peaks of accessible chromatin occur at TSSs. Meanwhile, some strong ATAC-seq signals are occasionally located downstream of transcription end sites (TESs), and these unusual peaks disappear in later embryonic stages. As an embryo develops, the number of open chromatin regions increases gradually, indicating that the chromatin becomes more accessible Lu et al., 2016) . The newly gained DHS sites appear at promoters and distal regions, including distal exons, introns, and intergenic regions. The accessible chromatin regions are largely maintained once established; for example, over 96% of zygotic DHS sites are maintained during preimplantation development. Genes with promoter DHS sites have higher expression levels than those without. Some inactive genes with accessible promoters are primed for activation at later stages of development. In mammals, the promoters of evolutionarily older genes gain accessibility at earlier development stages than those of younger genes, which is associated with earlier expression of the older genes .
Mammalian genomes are packaged into hierarchical highorder structures (Dekker and Mirny, 2016; Yu and Ren, 2017) . The topologically associated domain (TAD) appears to be the basic unit of structure and function, with a higher internal frequency of long-range chromatin interactions than other domains. TADs proceed to form higher-level structures called A and B compartments, which are associated with transcriptionally active and inactive states, respectively. Chromatin structure dynamics during early embryonic development in mice have been profiled by low-input Hi-C methods Ke et al., 2017; Rao et al., 2014) . In mice, the mature oocytes at the MII stage do not have TADs or compartments, similar to mitotic chromosomes (Ke et al., 2017) . In sperm, ultra-long-range interactions (>4 megabases) and interchromosomal interactions occur frequently (Ke et al., 2017) . After fertilization, the genome undergoes fundamental reorganization. The high-order structures of both the paternal and maternal genomes in zygotes and 2-cell embryos are obscure but are gradually reestablished through development Ke et al., 2017) . In addition, establishment of the TAD structure requires DNA replication but not ZGA. Until now, no data have been published showing the characteristics of chromatin high-order structures in human early embryos and gametes.
Cell lineage specification
After implantation, blastocysts develop into more heterogeneous cell types for cell lineage specification towards different organs and tissues. Traditional methods for study-ing these rapidly progressing and complicated processes are very limited. However, due to rapid advances in single-cell RNA-seq (scRNA-seq) and cell lineage tracing reporter systems, increasing molecular details on mammalian embryonic development from gastrulation to organ formation have been revealed. ScRNA-seq is a powerful tool for exploration of cell type, cell lineage, spatiotemporal trajectory, and gene function.
Some evidence has shown that the mechanisms controlling lineage specification during gastrulation are not entirely conserved between mice and humans. In the mouse, the compacted morula initiates trophectoderm (TE) and ICM specification. Two transcriptional factors, CDX2 and POU5F1 (also named Oct4), control this specification (Niwa et al., 2005) . In the mouse compacted morula and early blastocyst, Cdx2 is expressed in the outer cells, which represses POU5F1 expression. The differential expression pattern initiates specification and maturation of the TE and ICM and is driven by Fgf signaling in the blastocyst; the ICM subsequently specifies epiblasts (EPIs) and the primitive endoderm (PE) (Yamanaka et al., 2010) . In humans, unlike in mice, scRNA-seq data and antibody staining have clearly shown that TE and ICM specification coincides with the time of blastocoel formation (Petropoulos et al., 2016) . The TEdefining factor CDX2 is expressed only during blastocyst expansion and colocalizes with the pluripotency-associated factor OCT4 at E5 (Niakan and Eggan, 2013) . Surprisingly, EPI and PE lineage-specificity markers are detected at embryonic day 5 (E5), which indicates that all three lineages segregate simultaneously and that this segregation coincides with blastocyst formation at E5 (Petropoulos et al., 2016) . Beginning at E6, these coexpressed lineage genes start to become mutually exclusive. The details on the different molecular mechanisms that control three-layer cell lineage specification need to be further investigated.
Increasing evidence has shown that throughout embryogenesis, cells gain identity markers for their future cell fates and spatial locations much earlier than they demonstrate obvious morphological characteristics and spatial organization (Nowotschin et al., 2019; Pijuan-Sala et al., 2019) . For example, at mouse E8.25, the hepatic-related genes Hhex, Sfrp5, and Ttr10-12 and the lung-associated genes Ripply3 and Irx113/14 are already expressed in foregut cell clusters, which indicates that liver and lung precursors have already emerged by this stage (Pijuan-Sala et al., 2019 ).
The cardiovascular system consists of the heart and vascular system. The heart is the first functional organ to develop in embryos. During gastrulation, cardiovascular progenitors (CPs) leave the primitive streak (PS) and migrate to form the mesodermal cardiogenic fields at the anterolateral pole of the embryo. The mammalian heart is composed of ventricles, atria, and great vessels and includes diverse cell types, such as cardiomyocytes (CMs), en-dothelial cells (ECs), fibroblast-like cells, vascular smooth muscle cells (SMCs), and epicardial cells (EPs). Profiling of the single-cell transcriptomes of mouse early CPs has revealed that molecularly heterogeneous Mesp1+ CPs contain distinct cell populations corresponding to distinct cardiovascular lineages (Lescroart et al., 2018) . The gene expression patterns of Mesp1 knockout (KO) cells are similar to those of EPIs, indicating that Mesp1 cells fail to exit from the pluripotent state of EPIs. In Mesp1 KO cells, genes involved in the epithelial-mesenchymal transition (EMT) (Snai1 and Zeb2), migration (Rasgrp3), and cardiovascular specification (Etv2, Hand1, Myl7, Gata4, Flk1, and Pdgfra) are downregulated, indicating that Mesp1 is required for these critical events of cardiovascular system development. The transcription factor Tal1, which is responsible for blood cell development (Porcher et al., 1996) , was previously thought to be a gatekeeper of cardiac and blood fate transition within single multipotent mesodermal progenitors.
In mammals, many organs develop through rather conserved mechanisms. Mouse models are widely used to investigate human-related diseases (Van Handel et al., 2012) . Advances in transcriptomics have shown that significantly different molecular regulation occurs during organogenesis between humans and mice (Scialdone et al., 2016; Su et al., 2018) . Both human and mouse hearts originate from cardiac progenitors. However, heart size and heart rate are very different between humans and mice. Comparative analyses of scRNA-seq data for human and mouse hearts at several developmental stages have shown that human and mouse fetal hearts have markedly different gene expression patterns . The human-specific marker genes RNASE1 in ECs, THY1 in fibroblasts, and CFB and ITLN1 in EPs are absent in the mouse heart. However, in the mouse heart, Icam2 in ECs and Rnf213 in EPs are highly expressed. Cell type-specific development is asynchronous in mice and humans. Mouse CMs at E10.5 are most similar to human CMs at week7, while mouse ECs at E10.5 are most similar to human ECs at week 6.
Different gene regulatory mechanisms have also been found between human and mouse nephrogenesis (Lindstrom et al., 2018) . Some anchor genes for mouse nephron-specific genes identified in Genito Urinary Development Molecular Anatomy Project (GUDMAP) studies display similar expression in humans, such as SLC22A6 in the renal proximal tubule (PT) and ENTPD5 in the renal PT and in medial fragments of S-shaped bodies. While FBP1 is located only in the PT in mice, in humans, it is broadly expressed not only in the PT but also in the renal pelvis and the loop of Henle. More molecular characteristics need to be identified in humans and mice to facilitate in vitro human-related disease and regeneration research.
In summary, the advancement of new technologies has enabled the discovery of new cell types, new expression patterns, and new regulatory mechanisms in mammalian embryogenesis. In particular, scRNA-seq has played an important role in studies on the rapid and dynamic progression of gastrulation and organogenesis. However, most of the discoveries have been made in mice due to the scarcity of human embryo material. Research on large animal models (pigs, goats or nonhuman primates) or on differentiating human pluripotent stem cells in vitro will enhance understanding of human embryogenesis. In the coming years, we expect more advances to accelerate the resolution of longstanding questions about human prenatal embryogenesis.
FGC development
Single-cell transcriptomics for staging human FGCs
The first germ cell population during development is the primordial germ cells (PGCs), which are derived from EPIs and are the common precursors of both oocytes and sperm (Saitou and Miyauchi, 2016) . Mouse PGCs are specified in the most proximal posterior EPIs at the beginning of gastrulation. The induction of human PGCs is less clearly understood due to the inaccessibility of human early postimplantation embryos. In 2011, Hayashi et al. reported a novel strategy to efficiently generate mouse PGC-like cells (mPGCLCs) from mouse embryonic stem cells (mESCs) and mouse induced pluripotent stem cells (miPSCs) (Hayashi et al., 2011) . In 2015, Irie et al. and Sasakiet al. reported the generation of hPGCLCs from hESCs and hiPSCs using culture conditions similar to those used for mPGCLCs Sasaki et al., 2015) . Irie et al. showed that culture of hESCs/hiPSCs in "4i" medium, which endows cells with distinct pluripotency, can be used to induce hPGCLCs . Sasaki et al. showed that hiPSCs can be first induced to enter an incipient mesoderm-like cell (iMeLC) state and then induced to form hPGCLCs (Sasaki et al., 2015) . The efficiency of both methods can be as high as 50%-60%. These systems are invaluable for investigating the germ cell development.
After induction, human PGCs migrate to the gonadal ridge (the precursor of the gonads) at approximately week 5 postfertilization and undergo proliferation before sexual differentiation. A comprehensive transcriptome map of the development of female and male FGCs has been provided by recent scRNA-seq studies (Guo et al., 2015a; Li et al., 2017c) (Table 1) . Female FGCs progress through four sequential differentiation stages after colonizing the gonadal ridge: (i) the mitotic stage, (ii) the retinoid acid (RA)-responsive stage, (iii) the meiotic prophase stage, and (iv) the primordial follicle stage (Table 2) . Male FGCs progress through two stages after colonizing the gonadal ridge: (i) the mitotic stage and (ii) the mitotic arrest stage (Table 3) . Mitotic FGCs express both early PGC marker genes, such as PRDM1, POU5F1 and NANOG, and late germ cell-specific genes, such as DDX4 and DAZL. RA-responsive-stage female FGCs are characterized by expression of the RA target gene STRA8, which is essential for the mitosis-to-meiosis transition. Meiotic prophase-stage female FGCs express typical meiotic genes such as SYCP1, SYCP3, and SPO11. In primordial folliclestage female FGCs, oogenesis master genes such as ZP3 and NOBOX are highly expressed. In mitotic arrest-stage male FGCs, some cell cycle arrest-related genes, such as CDKN2B and NANOS2, are upregulated. The representative marker genes of each stage are provided in Tables 1 and 2 .
Epigenetic programming of FGCs
Gametes need to reset their epigenomes; in particular, the methylated imprinted regions must be erased completely and correctly reestablished . FGCs undergo global DNA demethylation shortly after specification. Whole-genome bisulfite sequencing (WGBS) studies have shown that the DNA methylation levels of FGCs are already reduced to low levels at the time of gonadal ridge colonization in both mice and humans (Gkountela et al., 2015; Guo et al., 2015a; Seisenberger et al., 2012; Tang et al., 2015) ( Table 1 ). The demethylation continues after colonization and is completed before sexual differentiation. In accordance with their different developmental routes, female and male FGCs reestablish sex-specific methylation patterns, includ-ing those of imprinting control regions (ICRs), through different routes (Lucifero et al., 2004) . Mouse studies have shown that de novo methylation commences in male FGCs in mitotic arrest, that the methylation levels of E16.5 male FGCs increase to about 50%; the paternal ICRs, such as H19 and IG-DMR, are highly methylated before birth (Henckel et al., 2012; Seisenberger et al., 2012) . In contrast, for female germ cells, de novo methylation largely commences after birth. The methylation levels of E16.5 female FGCs are still very low at approximately 10%, and maternal ICRs such as Snrpn, Igf2r and Peg1 are still unmethylated in postnatal day (D) 5 oocytes (Lucifero et al., 2004; Seisenberger et al., 2012) .
Oocyte development
In fetal ovaries, the oogonia, which develop from the PGCs on the surface of the gonadal ridge, further develop into primary oocytes after mitosis and first meiotic metaphase (MI). Oocytes must undergo two meiotic divisions (two rounds of chromosome segregation followed by one round of DNA replication) to reduce the number of chromosomes, transforming from diploid to haploid cells, and to gain the ability to fertilize. Maturation of mammalian oocytes involves a developmental process that is critical for the pro- duction of mature eggs capable of fertilizing and supporting the initial stages of embryonic development to the blastocyst stage. Mammalian oocytes are arrested at the diplotene stage of the first meiotic prophase for months or years, depending on the start of each estrous or menstrual cycle in different species (Tripathi et al., 2010) (Tripathi et al., 2010) . Oocytes at this stage contain large nuclei with pronounced nucleoli referred to as germinal vesicles (GVs). The key biological events of oogenesis are completed by the fetus stage, unlike those of spermatogenesis. Under the stimulation of the luteinizing hormone (LH) peak, only a small number of primordial follicles begin to develop and are selected as predominant preovulatory follicles after puberty. Subsequently, the enclosed oocytes within antral follicles obtain the capacity to resume meiosis, which is characterized by GV breakdown (GVBD). After GVBD and completion of MI, the oocyte arrests in MII with an extruded first polar body (PB1) and is released from the follicle into the oviduct until fertilization.
Therefore, oocyte development progresses through multiple stages; we will mainly focus on the development of the oocyte from birth to puberty, which involves MI arrest, resumption and MII arrest. Many factors influence these processes, including microenvironmental and endocrine factors and epigenetic and transcriptional regulation.
Transcriptional regulatory mechanisms of oocyte meiosis
During the highly regulated processes of oogenesis and folliculo genesis, the transcriptomic profiles of human oocytes and the bidirectional interactions between oocytes and surrounding granulosa cells (GCs) are highly complex. The comprehensive transcriptomic landscape of human oogenesis in adult ovaries has been investigated at single-cell resolution using scRNA-seq .
It is believed that development of an oocyte from MI to MII after meiosis is important because the quality of the egg depends on the formation and extrusion of the PB1 (Gupta et al., 2017) . At the molecular level, studies have shown that a variety of enzymes, factors and signaling molecules are involved in oocyte meiosis from MI to MII to ensure the high quality of the eggs (Miao et al., 2009) . For example, inactivation and reactivation of maturation-promoting factor (MPF), which includes a cyclin-dependent kinase-1 (CDK1) subunit, and its regulatory subunit cyclins is required for MI arrest and resumption in oocytes (Gautier et al., 1990; Masui and Markert, 1971 ). It will be of great interest to explore the mechanism of MPF activity regulation. When oocytes are arrested in MI, MPF is maintained at reduced levels through phosphorylation of threonines 14 and 15 on CDK1 (Lundgren et al., 1991; Mueller et al., 1995; Parker and Piwnica-Worms, 1992; Wells et al., 1999) . In response to the LH surge, oocytes begin to resume MI by activating MPF through dephosphorylation of CDK1 by cell division cycle 25B (Cdc25B) (Fesquet et al., 1993) . It is well known that cyclic adenosine 3′,5′-monophosphate (cAMP) must be maintained at high levels in oocytes to activate protein kinase A (PKA), further activating the nuclear kinase WEE1/MYT1 (Han et al., 2005) and ultimately inhibiting the expression of Cdc25B to prevent CDK1 activation.
The essential role and specific molecular mechanism of cAMP and cyclic guanosine monophosphate (cGMP) in maintaining oocyte meiotic arrest has been described in detail (Pan and Li, 2019; Sharma et al., 2018) . The substrate for cAMP formation is ATP. Recently, a study showed that KBTBD8, a female fertility factor in the KBTBD ubiquitin ligase family, affects pyruvate kinase, muscle 1 (PKM1) levels in oocytes via a KBTBD8-Erk1/2-Aurora A axis and then significantly reduces both PB1 extrusion and ATP content (Li et al., 2019c) . The oocytes may not have enough ATP as the substrate of cAMP, causing the levels of cAMP to be low, preventing MPF inactivation, and eventually leading to abnormal meiosis. It has been reported that cGMP of peripheral somatic cells in mouse follicles can inhibit the hydrolysis of cAMP by phosphodiesterase PDE3A after entering oocytes through gap junctions (Han et al., 2006) . More recent studies have shown that the LH peak could rapidly close gap junctions between somatic cells in the follicle, which partly explains why the emergence of the LH peak can cause the meiotic resumption of oocytes (Norris et al., 2008) . Thus, GCs in follicles also play an important role in the maintenance of meiotic arrest. This phenomenon was explained in a study in 2010, which showed that mural GCs and cumulus GCs in the mouse follicle expressed natriuretic peptide precursor type C (NPPC) and NPPC receptor 2 (NPR2), respectively. In vivo, deletions of Npr2 or Nppc can cause spontaneous meiotic resumption of oocytes (Zhang et al., 2010) .
In addition, the inactivation of MPF also depends on the ubiquitination and degradation of cyclins and the switch-like activation of the anaphase-promoting complex/cyclosome (APC/C), a large multi-subunit protein complex that is a ubiquitin E3 ligase and functions as the gatekeeper for mitotic exit (Reis et al., 2006; Thornton and Toczyski, 2006; Yang and Ferrell, 2013) . The synthesis and degradation of cyclins act synergistically with cyclin-dependent kinases (CDKs) to regulate the progression of meiosis and mitosis. B-type cyclins (cyclins B1, B2, and B3) are the primary cyclins in metaphase. Upon studying the specific function of Ccnb2, Marco Conti et al. reported that Ccnb2 -/oocytes underwent delayed GVBD and showed defects during the metaphase-to-anaphase transition, indicating that cyclin B2 is required for assembly of sufficient pre-MPF for timely meiosis reentry and progression (Daldello et al., 2019) . Therefore, Ccnb1 may not be able to fully compensate for loss of Ccnb2 in mouse oocyte meiosis .
Furthermore, studies have shown that Ccnb3 forms active kinase complexes with CDK1 and is necessary for APC/C activation to initiate anaphase I (AnaI) but is not required for oocyte maturation, MII progression, or early embryonic development (Karasu et al., 2019; Li et al., 2019a) . Aside from regulation of MPF activity, the spindle assembly checkpoint (SAC) plays an indispensable role in MI to ensure the correct separation of homologs. To prevent premature APC activation, the SAC recruits mitotic arrestdeficient (MAD, including MAD1, MAD2 and MAD3), budding uninhibited by benzimidazole (BUB, including BUB1 and BUB3) and MPS1 components, which play important roles in regulating meiotic progression during oocyte maturation (Gorbsky, 2015; Mihajlović and FitzHarris, 2018) . A recent study on porcine oocytes shows that Spindlin 1 (SPIN1) modulates the activation of the SAC and alters the metaphase-to-anaphase transition in MI by regulating the stability of BUB3 (Choi et al., 2019) .
Moreover, some recent studies on mouse oocyte meiosis have focused on another key family, the protein kinase C (PKC) family. Studies have shown that PKC is a multigene serine/threonine kinase family with multiple functions during oocyte meiotic maturation and that high levels of PKC maintain MI arrest in mouse oocytes (Mellor and Parker, 1998; Quan et al., 2003; Viveiros et al., 2004) . In a recent study, Yi et al. reported that depletion of PKCβ1, a member of the PKC family, results in defective spindles, while its overexpression delays G2/M progression through regulation of Ccnb1 and Cdc2. Therefore, PKCβ1 is an essential protein during meiotic maturation in oocytes (Yi et al., 2019) . PKC mu, an activated PKC isoform, is also called PKD1. A study showed that PKC mu plays an important role in oocyte maturation by regulating the phosphorylation level of cofilin for actin assembly and then affects spindle organization and actin filament distribution . In addition, a recent study suggested that PKCδ may be involved in regulation of the resumption of MI after arrest in mouse oocytes through phosphorylation of AKT1 at serine 473 . It has also been recently shown that PKCε contributes to connexin 43 (Cx43) phosphorylation by mediating mitogen-activated protein kinase (MAPK) signals in cumulus cells during follicle-stimulating hormone (FSH)induced oocyte meiotic resumption . These findings further demonstrate that PKCs have multiple functions in cell cycle progression during oocyte meiotic maturation.
After the completion of MI and the expulsion of the PB1, oocytes become arrested in MII. Maintaining MII arrest in mammalian egg cells requires stabilization of MPF activity, which is maintained by cytostatic factor (CSF) and the Mosmediated MAPK pathway, and proper spindle assembly through specific mechanisms (Madgwick and Jones, 2007; Perry and Verlhac, 2008; Shoji et al., 2006 ). An important component of CSF is the Emi/Erp protein family, which has only two known members: Emi1 and Emi2 (Schmidt et al., 2006) . Other proteins that maintain MII arrest in mammalian oocytes include Cyclin B, Mos (pp39 Mos), MAPK kinase (MEK), and MAPK (Kubiak et al., 1993; Madgwick and Jones, 2007) . Aside from the regulation of CSF and MAPK, precise spindle assembly is essential for the maintenance of MII arrest. Studies have shown that the proteins MAPK interacting and spindle stabilizing (MISS) and deleted in oral cancer one-related (DOC1R) act as MAP kinase substrates and play important roles in spindle assembly of MII-arrested oocytes (Lefebvre et al., 2002; Terret et al., 2003) . In addition, production of H 2 O 2 by the mitochondrial pathway may play an important role in MII arrest of mammalian oocytes (Goud et al., 2008) .
Epigenetic modifications in oogenesis
Proper meiosis and embryonic development require precise and drastic epigenetic modifications of mammalian oocytes that are different from those of somatic cells, such as DNA methylation (Kelsey and Feil, 2013) and histone modifications (LaVoie, 2005) . It is through these changes in germ cells that mammals ensure genetic diversity while transmitting genetic and epigenetic information to the next generation.
DNA methylation plays a critical role in regulating epigenetic inheritance and gene expression during oocyte maturation (Stewart et al., 2016) . Although a reduction in DNA methylation in oocytes has little effect by itself, affected embryos can only develop to 10.5 days, mainly due to the lack of methylation of maternally imprinted genes (Kaneda et al., 2004) . The establishment of DNA methylation is a dynamic process during oocyte development (Gu et al., 2019) . Yu et al. demonstrated that the CpG methylation pattern has been largely established in the GV phase, but it also undergoes large changes in subsequent developmental stages, especially in highly concentrated areas of CpG. However, non-CpG methylation is not enriched in specific genomic regions or for specific functional features and gradually accumulates as oocytes mature . In preovulatory oocytes, de novo methylation occurs on a locusby-locus basis (Smallwood et al., 2011) . Studies have shown that interaction between a DNMT (Dnmt3a) and a DNMTlike protein (Dnma3L) is critical for de novo methylation of oocytes (Bourc'his and Bestor, 2006; Bourc'his et al., 2001; Okano et al., 1999) . Depletion of Dnmt3a and Dnmt3L ultimately leads to broad declines in CpG and non-CpG methylation in oocytes (Shirane et al., 2013) . The expression levels of DNMT1, DNMT3A, and DNMT3B are high during human oocyte development . The importance of these proteins has also been demonstrated by the death of Dnmt3a/Dnmt3L-deficient embryos after implantation (Stewart et al., 2016) . However, Dnmt3b does not play a significant role in the de novo methylation process in oocytes, unlike in sperm (Shirane et al., 2013) . In addition, the total DNA methylation level of sperm is much higher than that of oocytes Kobayashi et al., 2012; Smith et al., 2014) . In addition to DNMTs, which function in oocyte DNA methylation remodeling, the histone variant H3.3 may be essential because of interactions of the Dnmt3a/ Dnmt3L complex with the histone H3 tail Li et al., 2011) . One study showed that deficiency of HIRA, a histone chaperone of H3.3, leads to DNA hypomethylation in mouse oocytes (Nashun et al., 2015) .
During maturation of mouse oocytes, in addition to global de novo methylation, histone modification occurs in different patterns. With oocyte development, histone acetylation (of H3K9, H3K18, H4K12 and H4K5) and methylation (of H3K4 and H3K9) increase gradually. In addition, large-scale deacetylation of chromatin histones occurs during oocyte meiotic maturation (Clarke and Vieux, 2015) . As mentioned above, H3K4me3 and H3K27me3 exist in nonclassic patterns by the low-input ChIP-seq during mouse oogenesis . Decreases in protective H3K4me2 mediated by KDM1B at differentially methylated regions (DMRs) and increases in permissive H3K36me3 have been found at sites destined for remethylation in growing mouse oocytes (Stewart et al., 2015) . Also, broad H3K4me3 domains are negatively correlated with hypermethylated domains in fully grown mouse oocytes (Dahl et al., 2016) . Overexpression of KDM5B leads to decreases in broad H3K4me3 distribution and global transcriptional reactivation . In addition, the histone methyltransferase mixed lineage leukemia 2(MLL2) may be an important regulator of the broad location patterns of H3K4me3 over large genomic regions in preovulatory oocytes (Hanna et al., 2018) . As the study of oocyte DNA methylation maintenance has continued to deepen, a series of chromatin-binding proteins have been discovered, such as UHRF1 (Li et al., 2018b; Maenohara et al., 2017) , Sall4 , TRIM28 (Messerschmidt et al., 2012) , and HIRA (Nashun et al., 2015) .
In addition to histone methylation, acetylation of canonical histones (H3 and H4) also participates in regulating the oocyte maturation process (Kageyama et al., 2007) . Deficiency of HDAC1 and HDAC2, which are histone deacetylases, leads to failure of oocyte maturation and declines in global transcriptional activity (Ma et al., 2012) . Aside from HDAC1 and HDAC2, histone deacetylase 8 (HDAC8) may play an essential role in the regulation of oocyte maturation. One report showed that disruption of HDAC8 leads to defective MI due to abnormal spindle assembly . Although deletion of HDAC8 does not affect fertility, conditional KO of HDAC8 in oocytes leads to infertility because of incorrect deposition of cohesion and failure of chromosome segregation (Singh et al., 2019) .
Posttranslational modifications (PTMs) in oocyte maturation
It is well known that protein PTM is important for a variety of biological processes. SUMOylation, a type of PTM that is closely related to correct spindle assembly, chromosome condensation and separation, has been reported to play an important role in regulating the meiotic cycle in oocytes (Wang et al., 2010) . Four SUMO isoforms (SUMO-1 through SUMO-4) are expressed in vertebrates, each of which is uniquely modified by interaction with different downstream target proteins (Kerscher, 2007) . Based on 97% protein sequence homology and immunoreagent specificity, SUMO-2 and SUMO-3 are labeled SUMO-2/3. Many studies have elucidated the expression patterns of SUMO-1, SUMO-2 and SUMO-3 in human and rodent gametes, but their specific regulatory functions during gametogenesis need further study (Khan et al., 2016) . SENP3, a deSU-MOylation protease, can affect GVBD and PB1 extrusion by regulating SAC, γ-tubulin organization and spindle morphogenesis in mouse oocytes (Huang et al., 2015a) . Another study has shown that SUMOylation is involved in the regulation of GVBD and protein kinase B (PKB or AKT) signaling pathways during mouse meiotic maturation . In addition, SUMOylation plays important roles in regulating the function of PLK1, a member of the conserved polo-like kinase family of serine/threonine kinases, during mouse oocyte meiotic maturation .
Extracellular vesicles (EVs) in oogenesis
Mammalian oocyte development is a sophisticated process involving complex regulatory networks. The microenvironment, including steroid hormones, exosomes, growth factors, enzymes, lipid droplets, cytokines and antiapoptotic factors, plays an integral role in oogenesis. Signal transduction between somatic and germ cells through gap junctions maintains a link between follicular growth and oocyte maturation (Di Pietro, 2016) . The somatic cells in follicles, including GCs and thecal cells, secrete different factors into the follicular fluid (FF) formed by the infiltration of capillaries (Ranjbaran et al., 2019; Rodgers and Irving-Rodgers, 2010) . Studies over the past few years have revealed that EVs, which are carriers for miRNA and mRNA, from the FF are important in the main stages of the reproductive process, including maturation and meiotic resumption of oocytes (Machtinger et al., 2017) .
In 2014, Diez-Fraile et al. found four differentially expressed miRNAs (3 upregulated and 1 downregulated) in EVs of the FF in younger compared to older women. The genes regulated by these miRNAs are involved in the regulation of follicle and oocyte development (Diez-Fraile et al., 2014) . In the same year, Santonocito et al. detected the expression of miRNAs and investigated whether they were exosome cargo; the researchers identified 32 exosomal miRNAs in human FF and determined that nine of them participated in the regulation of oocyte maturation and subsequent ovulation (Santonocito et al., 2014) . Several years later, Machtinger et al. detected exosomal miRNAs in human FF containing mature oocytes and characterized miRNAs related to fertilization and embryo quality (Machtinger et al., 2017) . Another study suggested that exosomal miRNAs in human FF may participate in the regulation of follicle and oocyte development (Martinez et al., 2018) .
Abnormality of oogenesis
The process of oocyte development and the regulatory mechanisms at different developmental stages from birth to puberty are summarized in Figure 1 . In addition to classic genes that regulate oocyte development, mutations in many genes have been found in clinical studies to lead to oocyte maturation arrest and fertilization failure. Oocyte maturation arrest is a primary female infertility syndrome characterized by constant production of immature oocytes (Beall et al., 2010) . A comparison of young and aged mouse oocytes revealed that the expression level of Atrx in aged female oocytes is significantly decreased and that loss of function (LOF) of Atrx may lead to increased aneuploidy of female gametes (Pan et al., 2008) . In addition, a significant decrease in the level of chromosomal Shugoshin2 in aged oocytes results in premature sister chromatid segregation, which plays an essential role in preventing cleavage of centromeric cohesins during MI (Llano et al., 2008; Lee et al., 2008) . Studies on human oocyte development have shown that the rate of aneuploidy ranges from 20% to 70% (Fragouli et al., 2011; Pacchierotti et al., 2007; Pellestor et al., 2006) . With the increasing depth of sequencing, high-resolution mapping has revealed decreases in recombination frequency and abnormal localization of chiasmata in oocytes of older women (Hussin et al., 2011) . At least 5% of all chromosomal abnormalities in all clinically recognized pregnancies are aneuploidy, which is one of the main causes of reproductive disorders and the most common genetic cause of developmental disorders such as trisomy and monosomy (Eichenlaub-Ritter et al., 2008; Hassold and Hunt, 2001) . Studies have demonstrated that 20%-30% of oocytes in reproductive glands are aneuploid, while only 1%-8% of sperm are aneuploidy Lu et al., 2012) . Oocyte meiosis is more prone to errors than sperm meiosis and can eventually lead to aneuploidy, and the incidence increases with the age of women. Studies have shown that 20% of oocytes in 35-year-old women have aneuploidy, but this percentage can reach 60% in women undergoing menopause (Kuliev et al., 2011) . The majority of oocyte aneuploidy is caused by Figure 1 Follicular development and oocyte maturation processes from childhood to puberty. A large number of primordial follicles are stored on the ovaries after birth. Under the action of FSH and LH, the primordial follicles continue to develop and are preferentially selected to become ovulatory follicles. The oocyte initiates meiotic resumption under the action of the LH peak and is further arrested in MII. This process involves transcriptional regulation, epigenetic modification, PTM regulation, and microenvironmental regulation. The classic pathway regulating MI arrest and resumption is the MPF regulation pathway. In addition, NPPC and NPR2 in GCs and PKCs (such as PKCβ1, PKC mu, PKCδ and PKCε) are also involved. CSF and MAPK play important regulatory roles in the MII phase arrest process. errors in MI. Recently, mutations in TUBB8, a primate-specific tubulin beta 8 class VIII gene, have been found to lead to oocyte maturation arrest at the MI stage Feng et al., 2016a; Feng et al., 2016b; Huang et al., 2017a; Xiang et al., 2018) . Another study has suggested that mutations of PATL2 in humans lead to oocyte arrest at the GV stage Huang et al., 2018; Maddirevula et al., 2017) . A Chinese research team recently defined a new female infertility phenotype, the oocyte death phenotype, that is mainly caused by mutation of Pannexin 1 (PANX1), a channel protein that is a member of the pannexin family (Sang et al., 2019) .
Spermatogenesis
Spermatogenesis and single-cell transcriptomics staging
Spermatogenesis is a complex and precisely regulated process that requires approximately 74 days in humans. Adult male testicular tissue contains spermatogenic cells of various stages. Spermatogonia (SPGs) are located at the basal compartment of the seminiferous tubule, and primary spermatocytes (SPCs) progressively move into the adluminal compartment of the seminiferous tubule, in which meiosis and spermiogenesis occur. Human SPGs can be divided into three morphologically distinct types: dark type A, pale type A, and type B SPGs. Spermatogonial stem cells (SSCs), which are a subset of undifferentiated SPGs capable of selfrenewal, are thought to reside in the population of dark type A and pale type A SPGs (Fayomi and Orwig, 2018) . SPGs produce primary SPCs through the mitosis-to-meiosis transition, which can be divided into five stages: leptotene, zygotene, pachytene, diplotene and diakinesis. Primary SPCs undergo the first meiotic division to form secondary SPCs, which undergo the second meiotic division to produce haploid spermatids.
Recently, several studies have provided scRNA-seq data for human adult spermatogenesis Hermann et al., 2018; Sohni et al., 2019; (Table 1) . Diff.ing SPGs express KIT and MKI67, consistent with their rapid proliferation. Diff.ed SPGs correspond to the preleptotene stage and express the RA signaling target gene STRA8, which is essential for the mitosis-tomeiosis transition. SPCs are divided into five cell populations corresponding to the five stages which are classified according to the chromosome behavior in the prophase of MI. The SPC7 population is a mixture of cells in diakinesis and secondary SPCs. The representative marker genes of each stage are provided in Table 4 . Spermiogenesis is the final stage of spermatogenesis. Through processes of nuclear concentration, acrosome formation and tail formation, the round sperm is transformed to the tadpole-like spermatid. A series of changes take place in the sperm nucleus. The histones are firstly replaced by the transition nuclear proteins, which are subsequently replaced by protamines, and the sperm nuclei are concentrated and shaped. The acrosome is produced from the Golgi body, which is a membrane-coated lysosomal structure. The sperm flagellum is composed of a cervical segment, a middle segment, a main segment and a caudal segment. The acrosome grows at one end of a round sperm cell, and pairs of centrioles within the cell begin to form the flagellum at the other end. The cervical segment contains proximal and distal centrioles, which produce the flagella axoneme. Other flagella formation-related proteins include the Nectins, Tektins, A-kinase anchor proteins, Septins, etc. Mutations of these genes lead to abnormal morphology of the sperm flagellum, including the recently identified CFAP69 and ARMC2 mutations (Coutton et al., 2019; He et al., 2019) .
Somatic cell types in testes
Several kinds of somatic cells exist in the testicular seminiferous tubules, including Sertoli cells, Leydig cells and testicular peritubular cells (TPCs). These cells constitute the testis microenvironment, which is essential for regulating spermatogenesis.
Sertoli cells play an important role in spermatogenesis. At week 6 of gestation, mesenchymal-derived progenitor cells differentiate into Sertoli cells (Byskov, 1986; Munger et al., 2013) . After differentiation, these cells produce anti-Mullerian hormone (AMH), which blocks the development of the female internal genitalia. Sertoli cells also secrete androgenbinding protein, which maintains high levels of androgens in the testis and epididymis (Ingraham et al., 2000) . High concentrations of adipocytokines may negatively affect Sertoli cell maturation and could negatively affect testis function (Wagner et al., 2019) .
Leydig cells are important components of the testicular stroma. Leydig cells in adult males are different from those in embryos. In adults, testicular Leydig cells are redifferentiated, and fetal testicular Leydig cells have disappeared (Chamindrani Mendis-Handagama and Siril Ariyaratne, 2001). The development of human Leydig cells can be divided into three stages: from 8 to 18 weeks of gestation, from 2 to 3 months after birth, and during pubertal maturation of the hypothalamic-pituitary-gonadal axis (Chamindrani Mendis-Handagama and Siril Ariyaratne, 2001; Prince, 2001; Svechnikov et al., 2010) . Leydig cells secrete the vast majority of the testosterone circulating in males after puberty. Synthesis of testosterone from cholesterol is a complex process involving a variety of mitochondrial enzymes, transporters and cytoplasm. Leydig cells secrete estrogen in late adolescence and are important sources of estrogen in testes. In addition, Leydig cells synthesize insulin-like factor 3, which mediates the migration of the testes into the scrotum through relaxin-family peptide receptor 2 (Bay and Anand-Ivell, 2014) .
TPCs are a kind of mesenchymal cells that are large and flat and can provide support for the seminiferous tubules. TPCs can regulate paracrine Sertoli cells and participate in the production and maintenance of the testicular barrier. In addition, TPCs play an important role in pushing testicular fluid containing dormant sperm into the testicular network (Mayerhofer, 2013) .
Reproductive diseases
Etiologies of female infertility
The number of women suffering from infertility in modern society is increasing. A British study has shown that one in eight women aged 16-74 years has experienced infertility (Datta et al., 2016) . In China, the prevalence of infertility is 25% among couples of reproductive age . Female infertility results from multiple etiologies, some of which affect ovulation, fertilization, implantation and subsequent placentation, leading to adverse pregnancy outcomes. These etiologies include endometriosis and polycystic ovary syndrome (PCOS), while some infertility is unexplained (Pisarska et al., 2019) . Although the mechanisms behind the diseases are complex and variable, im-provements in molecular biology techniques have enabled them to be elucidated gradually. We will focus on two important female infertility-related diseases: endometriosis and PCOS.
Endometriosis
Endometriosis is a common chronic disease that refers to the implantation and growth of endometrial tissues (glands and stroma) outside the uterus, mainly in areas of the pelvic cavity, including the ovaries, rectum and bowel, and even in more distant ectopic sites, such as the mammary glands, lungs and pleurae. Endometriosis affects 10%-15% of women of reproductive age, and the prevalence can be as high as 30% for infertile women (Defrere et al., 2008) . Classic theories of the pathogenesis of endometriosis suggest that retrograde menstruation and coelomic metaplasia are the origins of ectopic endometrium, which are widely accepted by researchers. A novel theory emerging recently suggests that stem cells contribute to the formation of endometriotic lesions. Current studies propose that altered cellular immunity, cytokines and genetics also play important roles in the development of endometriosis. Other factors theorized to contribute to the onset and progression of endometriosis include environmental factors and endocrine factors.
(1) Retrograde menstruation The implantation theory, first proposed by Sampson in 1927 (Zondervan et al., 2018) , is the dominant theory of the pathogenesis of endometriosis. Based on the phenomenon of menstrual reflux, the theory states that endometrial epithelial and stromal cells can flow backward during menstruation, enter the peritoneal cavity through the fallopian tubes, implant in the ovaries and pelvic peritoneum, and continue to grow there, ultimately causing pelvic endometriosis (Zondervan et al., 2018) .
As Linda C. Giudice (2004) stated, the retrograde menstruation theory is supported by epidemiological evidence that women with endometriosis have higher volumes of refluxed menstrual blood and endometrial-like tissue fragments than women without the disease (Giudice and Kao, 2004) . In nonhuman models, scientists have found that female baboons suffering from endometriosis experience a higher probability of retrograde menstruation (83%) than control baboons (51%) (D'Hooghe et al., 1996) . Clinical studies of obstructed or limited outflow tracts have further supported the retrograde menstruation theory. There is a high incidence of endometriosis in adolescent girls with congenital outflow obstruction. Similarly, female baboons suffer from endometriosis after ligation of the cervix (Burney and Giudice, 2012) . The propensity for endometriotic lesions to implant in the Douglas cul-de-sac (Dmowski and Radwanska, 1984) and the left part of the pelvis (Al-Fozan, 2003) also supports this theory. Retrograde menstrual effluent tends to accumulate in the posterior compartment of the pelvis under the influence of gravity, and the sigmoid colon blocks the dispersion of the retrograde refluxed menstrual fluid from the left fallopian tube and promotes the stagnation of the effluent (Burney and Giudice, 2012) .
The pathogenesis of peritoneal endometriosis most likely involves implantation of refluxed menstrual endometrium through the fallopian tubes. Accumulating data from epidemiological studies, clinical cases and animal tests provide evidence for the retrograde menstruation theory. However, retrograde menstruation is a common phenomenon in women, while only approximately 10% of women suffer from endometriosis (Klemmt and Starzinski-Powitz, 2018) . The theory of retrograde menstruation cannot explain some rare cases. For instance, women suffering from amenorrhea, women without menstrual regurgitation and women with abnormal fallopian tubes can also suffer from endometriosis (Suginami, 1991) . Although the retrograde menstruation theory is generally acknowledged, it still has limitations.
(2) Coelomic metaplasia Coelomic metaplasia has high potential for metastasis to the intestinal mucosa, bladder mucosa, peritoneum and endometrium. Meyer, a famous pathologist in the 19th century, first proposed the hypothesis that endometrial cells originated from metaplasia of the coelom (Zondervan et al., 2018) . His theory postulated that coelomic metaplasia with high metastatic potential was activated by ovarian hormones, menstrual blood and chronic inflammation and converted into endometrial tissue.
Rare clinical cases of nonmenstruating women suffering from Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome and endometriosis (Cho et al., 2009 ) favor the coelomic metaplasia theory. Women with MRKH exhibit varying degrees of Mullerian tube deficiency, such as congenital absence of the uterus and vaginal uterus without functional endometrium (Guerrier et al., 2006) . In women with this condition, endometrial lesions may be due to abnormal activation of genes in the peritoneum that are normally active during embryonic development of the female reproductive tract (Gaetje et al., 2007) . Cases of morphological transition from ovarian surface epithelium to endometriotic lesion tissue also support this mechanism. Some very rare cases of endometriosis in the extremities or in prostate cancer patients receiving high doses of estrogen therapy may also support the coelomic metaplasia theory.
The coelomic metaplasia theory may explain the occurrence of ovarian endometriosis. The coelomic epithelium covering the ovary and the serosa of the peritoneum could undergo a metaplastic change into endometrial tissue (Vercellini et al., 2014) . In addition, the coelomic metaplasia theory offers the most reasonable explanation for the occurrence of endometriosis in unusual clinical cases. However, it is still necessary to collect more basic, experimental, and clinical data to further verify the coelomic metaplasia theory in the future.
(3) Stem cell theory In recent years, researchers have proposed that stem cells participate in the formation of early-onset endometrial lesions based on the presence of stem cells in the endometrium and menstrual blood (Djokovic and Calhaz-Jorge, 2015) . Stem cells are a group of multipotent cells with self-renewal ability. All tissues in the human body differentiate from stem cells, which have the potential to regenerate various tissues and organs. Endometrial stem cells can detach into the abdominal cavity upon retrograde neonatal uterine hemorrhage, survive in the abdominal cavity over a long period of time and retain their differentiation potential. When the local microenvironment is suitable, these cells participate in the onset of endometriosis, especially in patients with premenstrual and adolescent endometriosis (Gargett et al., 2014) . Stem cells derived from bone marrow may also play a role in the pathogenesis of endometriosis. Cindy M. P. Duke and her colleagues detected donor-derived endometrial cells in endometrial specimens of leukemia bone marrow transplant recipients by RT-PCR and immunohistochemistry (Yang and Huang, 2014) . This finding may explain the etiology of some cases of extra-abdominal endometriosis. However, new questions have arisen as to whether newborns with uterine bleeding are likely to suffer from endometriosis in the future. More experiments are needed to explore the roles of stem cells in the pathogenesis of endometriosis. Detection of stem cells involved in the onset of endometriosis may contribute to new diagnostic methods and specific therapies for patients.
(4) Immunity and inflammation The local microenvironment is important for the onset and progression of endometriosis. Dysfunctions of immunity have been found in patients with endometriosis, mainly manifesting as aberrations in immune cell quantity and function, autoantibody generation and cytokine level fluctuations.
Altered cellular immunity. It is believed that a lack of immune surveillance, recognition and destruction in the peritoneum is a cause of endometriosis (Giudice and Kao, 2004) . Defective macrophages, natural killer (NK) cells and T-cells may fail to inhibit ectopic endometrial cell proliferation and thus promote the progression of ectopic endometrial lesions.
Macrophages. One of the main functions of macrophages is scavenger receptor-mediated phagocytosis. Peritoneal macrophages in patients are activated, but their phagocytic activity is decreased (Lebovic et al., 2001) . The defective phagocytosis by macrophages in endometriosis is associated with downregulation of scavenger receptor expression (Chuang et al., 2009) . Endo I, a protein structurally similar to haptoglobin, was recently discovered in endometriotic epithelial cells by Sharpe Timms through the proteomics ap-proach of two-dimensional gel electrophoresis. This protein binds to macrophages in the abdominal cavity and impairs macrophage-mediated phagocytosis by blocking adhesion. Researchers have proposed inhibition of haptoglobin activity as a potential therapeutic strategy (Sharpe-Timms et al., 2002) .
NK cells. As major components of the innate immune system, NK cells have the innate ability to distinguish malignant cells from normal cells (Angka et al., 2017) . Decreased cytotoxicity of NK cells in peritoneal fluid may promote escape of ectopic endometrial cells from epidemic surveillance and boost the development of ectopic lesions. Altered cytokines in peritoneal fluid are the underlying causes of NK cell dysfunction. For example, increased IL-6 in the abdominal cavity generated by ectopic endometrium impairs the cytotoxicity of NK cells through modulation of protein tyrosine phosphatase (SHP-2) expression (Kang et al., 2014) . Platelet-derived TGF-β produced by ectopic endometrial cells reduces the expression of NKG2D receptors (subtypes of KAR that stimulate cytotoxic activity), resulting in declining NK-mediated cytotoxicity in women with endometriosis .
T-cells. T-cells are specific immune cells that include Thelper (Th) cells, T-suppressor cells, T-killer cells and cytotoxic T-cells. Th1/Th2 imbalance is associated with endometriosis. When the anti-inflammatory effect of Th2 exceeds the proinflammatory effect of Th1, the immune defense mechanism is destroyed, and ectopic endometrial cells escape immune surveillance (Zhang et al., 2018a) .
Regulatory T-cells (Tregs) originating from CD4 are some of the key regulators of the immune process in endometriosis. Activation of Tregs can suppress the effector T-cell proliferation response. Studies have indicated that the concentrations of Tregs in peritoneal fluid are significantly increased in women suffering from endometriosis compared to control subjects. Hence, Tregs suppress the T-cell immune response and fail to inhibit ectopic endometrial cell proliferation (Yoshimura et al., 2010) .
Autoimmune dysregulation. A postulated autoimmune etiology of endometriosis derives from reports of increased polyclonal B-cell activity, abnormalities in B-and T-cell function, familial inheritance, high B-cell and T-cell counts, and reduced NK cell activity. High levels of IgG, IgA, and IgM auto antibodies and antibodies to the endometrium have also been reported (Giudice and Kao, 2004) . A retrospective cohort study conducted by American scholars indicated that the autoimmune inflammatory diseases systemic lupus erythematosus (SLE), Sjögren's syndrome (SS), rheumatoid arthritis (RA) and multiple sclerosis (MS) occur more frequently in women with endometriosis than in women without endometriosis (Sinaii, 2002) . However, the study had limitations resulting from misclassification of diseases and inaccurate prevalence rates. Further studies and more data are needed to confirm this hypothesis.
Cytokines. Cytokines are a wide range of low-molecularweight regulatory proteins secreted by leukocytes and endometrial and mesothelial cells that participate in cell signaling. They are thought to participate in the reduction in endometrial cell immune surveillance, recognition and destruction and to contribute to the progression of endometriosis (Coutinho et al., 2019) . Compared with healthy women, women with endometriosis exhibit apparently increased levels of IL-1, IL-6, IL-8, IL-10 and some other cytokines in peritoneal fluid (Asghari et al., 2018) . A large number of studies have shown that these cytokines can stimulate the proliferation of endometrial cells and increase the angiogenesis of ectopic endometrium.
IL-1β can induce the expression of VEGF; in turn, VEGF stimulates capillary proliferation by binding to specific receptors on vascular ECs, which promotes the invasion of the endometrium and forms ectopic lesions . Elevated levels of IL-6 are associated with decreased cytotoxicity of NK cells (Sikora et al., 2011) . The immunosuppressive effect of IL-10 inhibits T-cell proliferation and NK cell activity and may be beneficial in reducing lesion size, while administration of IL-10 promotes the progression of the disease (Suen et al., 2014) . IL-16 stimulates proinflammatory cytokines such as IL-6, TNF-α, and IL-1β and results in the development of endometriosis (Koga et al., 2005) . TNF-α can increase local vascular permeability, which may cause inflammatory factors to penetrate the pelvic cavity, aggravating peritoneal inflammation (Richter et al., 2005) .
(5) Genetic basis Family and twin studies have indicated that gene susceptibility plays a role in disease development (Burney and Giudice, 2012; Deiana et al., 2019) . The risk for first-degree relatives of women with severe endometriosis is six times higher than that for relatives of unaffected women (Deiana et al., 2019) . Studies of monozygotic twins have showed high concordance rates for histologically confirmed endometriosis (Burney and Giudice, 2012) . Many genes have been suggested to be involved in the initiation or progression of endometriosis, including genes associated with cell cycle regulation, cell adhesion molecules, inflammatory responses, growth factors and hormone receptors. Also, genetic factors, including microsatellite instability (MSI), chromosomal instability (CIN), single nucleotide polymorphism (SNP), gene mutation (GM), loss of heterozygosity (LOH), and mitochondrial DNA (mtDNA) mutations, have been suggested to contribute to endometriosis susceptibility and progression (Asghari et al., 2018) . Various epigenetic aberrations may also play important roles in the pathogenesis of endometriosis (Koukoura et al., 2016) . Aberrant DNA methylation is a possible mechanism linking gene expression alterations observed in endometriosis with hormonal and environmental factors (Koukoura et al., 2016) . Studies have also suggested that ncRNAs, including siRNAs, miRNAs and lncRNAs, are key contributors to the disease process (Panir et al., 2018) . However, current genetic and epigenetic studies have revealed inconsistent and contradictory evidence and not provide simple and univocal answers to the etiology of endometriosis. Future genome-wide association studies (GWASs) may be possible to find rare genetic variants associated with endometriosis in order to understand the molecular mechanisms of the pathogenesis, development and maintenance of endometriosis (Deiana et al., 2019) .
(6) Environmental factors Researchers have proposed that environmental factors have an impact on the development of endometriosis. Dioxins, which are environmental toxins, have been confirmed to be associated with endometriosis. Epidemiological investigation has revealed that the incidence of endometriosis is higher in regions with severe dioxin pollution than in lesspolluted regions. A case-control study of 80 women with no birth history in Italy suggested that the levels of the dioxinlike compounds polychlorinated biphenyls (PCBs) in peripheral blood were significantly higher in women with endometriosis than in control group (Porpora et al., 2006) . In Rier's rhesus monkey experiment in 1993, monkeys were given different doses of dioxins, and his results suggested that the incidence and severity of endometriosis are positively correlated with dioxin dose (Rier et al., 1993) . The specific pathogenesis of dioxin-induced endometriosis is still unclear. Scientists speculate that dioxins can interfere with the endocrine system and affect immune regulation, thus promoting the development of endometriosis. Scholars have found that tetrachlorodibenzo-p-dioxin (TCDD, the most toxic dioxin compound) can upregulate upon activation normal T-cell expressed and secreted (RANTES), causing macrophage aggregation, increasing the invasiveness of endometrial stromal cells, and participating in the occurrence of endometriosis (Yu et al., 2008) . Epidemiological studies and animal experiments have shown that the development of endometriosis may be related to exposure to environmental factors such as dioxins; however, the research in this field is still incomplete, and the dioxin-mediated pathogenesis of endometriosis needs further elucidation. The phenomenon of dioxin-induced endometriosis may somehow provide a new way to prevent the occurrence of endometriosis.
(7) Endocrine factors The regulation of the endometrium is closely associated with cyclic changes in estrogen and progesterone. Estrogen, especially estradiol, induces proliferation of the endometrial stroma and glands, while progesterone antagonizes estrogen and restricts the growth of the endometrium. Since endometriosis is a hormone-dependent disease, imbalance between estrogen and progesterone is an important factor in its pathogenesis (Critchley and Saunders, 2009 ). Elevations in estradiol during menstruation in women with endometriosis are related to abnormal expression of several enzymes, such as aromatase and 17 β hydroxysteroid dehydrogenase (17-HSD) (Asghari et al., 2018) . Progesterone resistance also plays a vital role in the pathogenesis of endometriosis. The Italian researcher Lattuada and her colleagues found that progesterone resistance might result from polymorphism in a progesterone gene called PROGINS, which downregulates the expression of the progesterone receptor (Lattuada et al., 2004) . However, hormones may not be the only trigger of endometriosis, as there are a number of case reports and retrospective studies of postmenopausal endometriosis in women with no symptoms and no endometriosis history (Inceboz, 2015) . Since ovarian function declines after menopause, leading to reduced estrogen secretion, postmenopausal women should theoretically not suffer from endometriosis. Hence, some other factors must be involved in the pathogenesis of endometriosis.
(8) Summary Each theory is supported by epidemiological data or experimental evidence. However, none of the hypotheses can completely explain the etiology of endometriosis. Further studies are needed to better understand the pathogenesis of endometriosis and provide new ideas for the diagnosis, treatment and prevention of the disease.
PCOS
PCOS is the most common endocrinopathy in women of reproductive age and is characterized by hyperandrogenism, anovulation or oligo-ovulation and ovarian polycystic changes. Given the strong clinical heterogeneity of PCOS, the disease currently has three main diagnostic criteria. According to the Rotterdam criteria, approximately 8%-13% of women of childbearing age suffer from PCOS (McCartney and Marshall, 2016) . PCOS is so complex that there is no single factor that can explain its development. Current research indicates that genetic, epigenetic and environmental interactions result in the clinical manifestations of PCOS.
(1) Genetic basis The strong trend of familial aggregation of PCOS and its related traits suggest an underlying genetic basis (Cooper et al., 1968) . Cooper et al. were the first to report the hereditary potential in PCOS. Several studies have supported that hypothesis, reporting increased prevalence of PCOS or its related traits among the family members of PCOS probands (Ferriman and Purdie, 1979; Kahsar-Miller et al., 2001; Kent et al., 2008; Legro et al., 1998; Lunde et al., 1989) .
Twin studies have been extremely effective in distinguishing between the influences of genetic and environmental factors on phenotypic variation in multiple conditions, and initial studies in a small cohort of monozygotic and dizygotic twin pairs have suggested that PCOS does not result from a single autosomal genetic defect but rather from environmental or polygenic factors (Jahanfar et al., 1995) . A very large subsequent twin study with 1,332 monozygotic twins and 1,873 dizygotic twins/singleton sisters of twins revealed that the overall heritability for PCOS was 0.72 and that the resemblance in monozygotic twin sisters for PCOS was approximately twice that in dizygotic twins and other sister pairs (0.71 vs. 0.38), suggesting a large genetic influence on the pathogenesis of PCOS (Vink et al., 2006) .
During the past decades, most genetic studies on PCOS have used the candidate gene approach, which involves investigation of the correlations of variants of a gene of interest with the PCOS phenotype or its quantitative traits. According to the PolyCystic Ovary Syndrome Knowledge Base (PCOSKB, http://pcoskb.bicnirrh.res.in) (Joseph et al., 2016) , a curate database of PCOS-related information from the scientific literature, 241 genes and 117 SNPs associated with PCOS have been identified to date; however, very few PCOS susceptibility genes have been replicated.
Hyperandrogenism is currently thought to be central to the pathogenesis of PCOS; many studies have therefore explored variants of genes involved in androgen biosynthesis and activity. A number of studies have reported the associations of polymorphic CAG repeats in the AR gene with PCOS risks but have presented conflicting results. Mifsud et al. reported that short CAG repeat length in AR was associated with a subset of anovulatory PCOS patients with low serum androgens (Mifsud et al., 2000) , while Hickey et al. observed longer CAG repeat alleles in PCOS patients that were correlated with increased serum testosterone (Hickey et al., 2002) . A systematic review and meta-analysis found that the AR CAG repeat polymorphism is unlikely to be a major determining factor in the development of PCOS . Variants in CYP17A1, CYP19A1, and CYP11A1, a series of genes coding key enzymes for androgen biosynthesis, have been reported to be associated with PCOS (Echiburu et al., 2008; Gaasenbeek et al., 2004; Kahsar-Miller et al., 2004; Petry et al., 2005 Petry et al., , 2006 Wang et al., 2006) .
Insulin resistance is also a profound phenotype of PCOS, and INSR is the only candidate gene that has been subsequently validated by GWASs. Although a number of studies have investigated the association between SNPs of INSR and PCOS, the results have been highly controversial. Initial studies on the INSR locus identified the polymorphic variant D19S884 in intron 55 of the fibrillin-3 gene, 1 cM telomeric to the INSR gene, as a potential susceptibility factor for PCOS (Tucci et al., 2001) . Replications of association between D19S884 and PCOS in several independent cohorts have been subsequently reported (Ewens et al., 2010; Urbanek et al., 2005; Xie et al., 2013) , although a smaller Spanish study found no relationship between D19S884 and PCOS (Villuendas et al., 2003) . In total, 98 SNPs distributed in 23 exons and the flanking regions of INSR have been investigated, among which 17 SNPs have been found to be associated with PCOS (Feng et al., 2015) . However, a metaanalysis concluded that only rs2059807 of INSR might be involved in susceptibility to PCOS (Feng et al., 2015) .
PCOS is regarded as a proinflammatory condition, and chronic low-grade inflammation has been found to be closely related to PCOS. A number of studies have investigated the association of polymorphisms in inflammatory cytokine genes, such as TNF-α, IL-6, and IL-1 β, with PCOS incidence .
One obvious drawback of the candidate gene approach is that only one or two variants in each gene of interest can be genotyped at a time. With improvements in high-throughput genetic technologies enabling assay of hundreds of thousands of SNPs at the same time, GWASs have become efficient tools for defining risk loci in PCOS as well as other complicated diseases. The first GWAS on PCOS, reported by Chen et al. in 2011, revealed strong evidence of associations between PCOS and three loci in a Han Chinese population: 2p16.3 (rs13405728 in the LHCGR gene), 2p21 (rs13429458 in the THADA gene), and 9q33.3 (rs2479106 in the DENN-D1A gene) . A larger-scale follow-up study by the original authors confirmed the three loci previously reported and identified eight new candidate loci in/near the genes C9orf3, YAP1, RAB5B/SUOX, HMGA2,TOX3, INSR, and SUMO1P1 and a second independent signal at FSHR . Two additional GWASs were carried out in Koreans, but because of their smaller size, these studies could not replicate the loci identified by GWAS in Chinese subjects; however, they identified a novel signal at 8q24.2 (rs10505648 in KHDRBS3) (Hwang et al., 2012; Lee et al., 2015) .
In 2015, two GWASs on European populations added to our understanding of the genetic basis of PCOS. Hayes et al. (Hayes et al., 2015) reported on a GWAS involving 984 PCOS patients diagnosed by NIH criteria and 2,694 controls, followed by two replication cohorts with 1,799 and 217 patients and 1,231 and 1,335 controls, respectively, and identified three significant genome-wide loci: two novel loci (chr 8p32.1 and 11p14.1) and a chr 9q22.32 locus previously found in Chinese PCOS. Day et al. (Day et al., 2015) performed a GWAS involving 5,184 self-reported PCOS cases and 82,759 controls, with replication in 2,045 clinically validated cases and 98,886 controls. The authors identified six signals for PCOS with genome-wide statistical significance in/near the genes ERBB4/HER4, YAP1, THADA, FSHB, RAD50 and KRR1.
(2) Epigenetic basis Epigenetic mechanisms, including DNA methylation, histone modification, and transcriptional and posttranscriptional regulation by ncRNAs, have been widely connected to the development of PCOS.
DNA methylation. According to the developmental ori-gins of health and disease (DOHaD) hypothesis, an unfavorable prenatal environmental may lead to persistent changes in the epigenome, such as increased or decreased DNA methylation at CpG sites, and result in elevated susceptibility to certain adult diseases (Gluckman et al., 2009 ). From experimental studies on animal models, there is conclusive evidence that exposure to excessive androgens during fetal life produces a comprehensive adult PCOS-like phenotype owing to perturbation of the epigenome (Abbott et al., 2009; Xu et al., 2011) . It is worth noting that this effect can be transgenerationally inherited for several generations through gametes (Xu et al., 2014) . Abbott and his team, who established a prenatally androgenized (PA) rhesus monkey model to study the fetal origins of PCOS in the last century (Abbott et al., 2005; Abbott et al., 1998; Abbott et al., 2002; Dumesic et al., 2007) , used genome-wide site-specific methylation analysis to measure methylation levels at 27,578 CpG sites in visceral adipose tissues of infant and adult model monkeys . The researchers identified numerous differentially methylated sites between PA and control monkeys, including 163 sites in infants and 325 sites in adults. These sites were enriched for several significant pathways, such as TOB-related antiproliferative T-cell signaling and transforming growth factor-β signaling. In addition, hypomethylation of specific CpG sites in the promoter region of steroidogenic genes (GATA-binding protein, GATA6, and steroidogenic acute regulatory protein, StAR) has been observed in PA rats (Salehi Jahromi et al., 2018) .
To study methylation differences between PCOS patients and controls, epigenome-wide association studies (EWASs) have been performed using high-throughput techniques. Xu et al. first detected DNA methylation in peripheral blood leukocytes (PBLs) of 20 PCOS patients and 20 controls and found no significant differences in methylation (Xu et al., 2010) . In contrast, in a study by Shen et al., 40 differentially methylated genes were found (Shen et al., 2013) . In 2016, Li et al. used a new detection platform with an expanded sample size. After adjustment for multiple tests, 699 CpGs were found to be differentially methylated, and they were linked to 273 genes significantly involved in 22 biological pathways (Li et al., 2017d) . There have been 10 studies targeting ovarian cells and GCs to date Pan et al., 2018; Qu et al., 2012; Sagvekar et al., 2019; Sagvekar et al., 2017; Wang et al., 2014b; Wang et al., 2014c; Xu et al., 2016; Yu et al., 2013 Yu et al., , 2015 . Although each study has identified large numbers of differentially methylated genes, the findings have been inconsistent. For example, Qu et al. (Qu et al., 2012) reported differential methylation levels of CpG sites in the peroxisome proliferator-activated receptor gamma 1 (PPARG1, hypermethylation) and nuclear corepressor 1 (NCOR1, hypomethylation) promoters in GCs between a hyperandrogenic PCOS group and a non-hyperandrogenic PCOS group. Xu et al. examined the differences between PCOS obesity and non-obesity groups and found that the differentially methylated genes were enriched for developmental protein, transcription factor activity, alternative splicing, sequence-specific DNA binding and embryonic morphogenesis terms . A recent study combined DNA methylome profiling and transcriptional expression profiling of GCs to identify differentially methylated genes contributing to ovarian defects in PCOS (Sagvekar et al., 2019) . Pan et al. found hypomethylation of several gene promoters related to lipid and steroid synthesis, such as BCL2-Interacting Protein 3 (BNIP3) and nuclear receptor subfamily 4 group A member 1 (NR4A1), which may result in hyperandrogenism in the context of PCOS (Pan et al., 2018) . In addition, several studies have also been performed on adipose tissue (Kokosar et al., 2016) and skeletal muscle tissue (Nilsson et al., 2018) . However, probably due to tissue-specific expression patterns of DNA methylation, the interesting results from the different EWASs have been inconsistent.
ncRNAs. Among the ncRNAs, miRNAs are the most well-studied ncRNAs in the context of PCOS; these RNAs play critical roles in gene regulation at the posttranscriptional level by specifically binding to the 3′UTRs of target genes and influencing cell proliferation, differentiation, apoptosis and other processes (Chen et al., 2019) . Numerous studies have shown that miRNAs exist in large quantities and are relatively stable in serum, FF (Sorensen et al., 2016b) , GCs , thecal cells (Lin et al., 2015) , and cumulus cells . Differentially expressed miRNAs in serum and FF can be used as biomarkers of obesity (Murri et al., 2018) , impaired glucose metabolism (Jiang et al., 2016) , ovulation disorders (Eisenberg et al., 2017) , hyperandrogenism (Arancio et al., 2018; Sorensen et al., 2016a) , ovarian hyperstimulation syndrome (Zhao et al., 2015) and blastocyst development (O'Doherty et al., 2018) . However, differentially expressed miRNAs in GCs are associated with the pathophysiological processes of PCOS. For example, miRNA-9 (Kong et al., 2019) , miRNA-16 , and miRNA-19b (Zhong et al., 2018) have been found to promote ovarian GC proliferation and to suppress apoptosis. MiRNA-99 (Geng et al., 2019) , miRNA-335-3p , and miRNA-324-3p (Jiang and Ma, 2018) exert completely opposite effects. MiRNA-323-3p regulates steroidogenesis by targeting IGF-1 , and miR-92 is related to androgen biosynthesis (Lin et al., 2015) .
In recent years, a large number of studies have begun to pay attention to the roles of lncRNAs in the pathogenesis of diseases. However, little is known about the roles of lncRNAs in follicular development, steroidogenesis, and PCOS . LncRNAs in GCs from women with PCOS with or without hyperandrogenism were profiled by Jin et al. using microarray screening. A total of 3,000 and 1,030 differentially expressed lncRNAs were found in PCOS patients with hyperandrogenism compared to controls and compared to PCOS patients without hyperandrogenism, respectively. Another study found that 862 lncRNA transcripts and 998 mRNA transcripts were differentially expressed in PCOS GCs compared with control GCs . The expression levels of the lncRNA human leukocyte antigen complex group 26 (HCG26) are upregulated in PCOS and are associated with antral follicle counts. When HCG26 is knocked down in KGN cells, cell proliferation and cell cycle progression are inhibited, while aromatase gene expression and estradiol production are increased. In addition, the lncRNA H19 (Qin et al., 2019) , BANCR , SRA , LINC-01572:28 (Zhao et al., 2018) , GAS5 , and LET (Han et al., 2018) have also been demonstrated to be key regulators in the pathogenesis of PCOS.
Furthermore, newly appreciated RNA molecules, circular RNAs (circRNAs), have also been linked to the pathogenesis of PCOS. However, at present, only expression profile analyses have been conducted (Che et al., 2019; Ma et al., 2019; Wang et al., 2019a; Zhang et al., 2019a) ; the specific mechanisms remain to be studied.
Alternative splicing. Alternative splicing is an important posttranscriptional regulation mechanism that enables a gene to be translated into multiple proteins. There have only been two studies on alternative splicing in PCOS. One of them focused on the Androgen Receptor (AR). Wang et al. identified two alternative splice variants (ASVs) of the AR, insertion and deletion isoforms, which were strongly associated with marked hyperandrogenism and abnormalities in folliculogenesis via targeting of CYP17A1 and CYP19A1. In another study, Tee et al. (Tee et al., 2016) also focused on hyperandrogenism. DENND1A was found to encode two principal variants, V1 (1,009 amino acids) and V2 (559 amino acids), in the studied cells. Overexpression of V2 induces androgenproduction, and vice versa.
(3) Environmental factors Recent studies have shown that environmental endocrine disruptors are associated with the development of PCOS (Goodarzi, 2008) . Some substances in the environment (such as disposable plastic products) enter the human body directly or indirectly and can affect hormone metabolism, disrupt the balance of human androgens and become high-risk factors for the onset of PCOS. Environmental endocrine disruptors may disrupt the metabolic functions of the ovaries and the body. Bisphenol A, one such endocrine disruptor, is a plasticizer that is widely used in daily life and has a weak estrogen effect. Studies have shown that serum bisphenol A levels in adolescent women with PCOS are significantly higher than those in normal adolescent women, and serum bisphenol A levels are positively correlated with total testosterone, free testosterone, and dehydroepiandrosterone levels (Akin et al., 2015) , suggesting that accumulation of bisphenol A in the body may increase the risk of developing PCOS.
The pathogenesis of PCOS can be traced back to the stages of embryonic development. Since PCOS is a combination of diseases with the same phenotype (Goodarzi, 2008) , researchers have proposed that hyperandrogen exposure at any stage can lead to the appearance of typical symptoms of PCOS, such as insulin resistance and ovulation dysfunction (Ibanez et al., 1998) . Changes in the endocrine environment during pregnancy in PCOS patients with hyperandrogenemia as the main clinical manifestation may be one of the underlying causes of long-term PCOS in fetuses (Abbott et al., 1998; Barker, 1990; Puttabyatappa et al., 2016; Raassen et al., 2018) . Another study found that low-birth-weight infants can develop early insulin resistance in their early growth and catch-up phases, which may further cause precocious puberty and hyperandrogenic symptoms in adolescence and eventually lead to PCOS in adult females (Baldelli et al., 2002) . Patients with adrenal hyperplasia caused by 21-hydroxylase deficiency and congenital male adrenal tumors are exposed to excessive androgen levels in the uterus during the fetal period. Even after treatment has been administered and the androgen levels have become normal, the adult will show a series of typical symptoms of PCOS, such as functional ovarian hyperandrogenism, high secretion of LH, ovulation disorders and polycystic ovaries, as well as central obesity and insulin resistance (Hague et al., 1990; Salem et al., 1994) . Thus, a series of endocrine and reproductive changes after exposure to high androgens during the fetal period may eventually lead to the development of PCOS.
Dietary energy and structure play an important role in the development of PCOS. Approximately 30% of obese women have PCOS, compared with only 5% of women with normal body mass. In addition, obese PCOS patients have more severe endocrine and metabolic disorders than non-obese PCOS patients (Barr et al., 2011) . Lifestyle changes, such as physical exercise, weight loss, and a balanced diet, can improve insulin resistance and hyperandrogenism, thereby significantly reducing the symptoms associated with PCOS patients, improving their metabolic abnormalities, regular ovulation cycle, and even enabling the patient to have successful pregnancy.
(4) Immune factors In 2001, Kelly et al. found that serum C-reactive protein was elevated in patients with PCOS (Kelly et al., 2001) . Several subsequent studies have suggested that PCOS may be a chronic state of low-grade inflammation (Benson et al., 2008) . Peripheral blood lymphocyte, monocyte, and eosinophil levels are increased in PCOS patients, and macrophage and lymphocyte infiltration are increased in the ovarian tissues of these patients, suggesting that inflammatory cell proliferation can lead to insulin resistance and hyperandrogenemia. Obesity can cause abnormal se-cretion of cytokines and inflammatory factors. Blood tests on obese adolescent PCOS patients have shown that blood leptin, tumor necrosis factor-d, and hypersensitive C-reactive protein levels are significantly increased. The combination of these factors increases insulin resistance, affecting follicular development and eventually leading to ovulation disorders (Anderson et al., 2014) . Increased secretion of IL and TNF in peripheral blood of PCOS patients stimulated by lipopolysaccharide (LPS) may contribute to insulin resistance and hyperandrogenemia independent of obesity, indicating preactivation of monocytes in the peripheral blood of PCOS patients (Gonzalez et al., 2014; Niccoli et al., 2011) .
In PCOS rats pretreated with anti-inflammatory drugs, body weight, ovarian weight, circulating follicle numbers, blood glucose levels, and estrogen levels are elevated, while the number and activity of T-cells (CD4 and CD8) in the ovaries, infiltration of macrophages in the ovaries, and production of IL-1β, IL-6, TNF-α, IL-8, monocyte chemoattractant protein-1 and nitric oxide in the ovaries are reduced (Jang et al., 2014) . At present, the specific mechanism of inflammation involved in the pathogenesis of PCOS is still unclear and needs to be further studied.
(5) Mental and psychological factors At present, research on PCOS has been conducted in many fields, such as genetics, biochemistry, immunity, and nutrition, but there have been few studies on mental and psychological factors.
The hypothalamus is the central nervous system component that regulates the body's internal secretions and emotions. When emotions fluctuate, they affect the normal operation of the endocrine system. Multiple studies have shown that patients with PCOS experience reduced quality of life, depression and a lack of self-confidence (Coffey and Mason, 2003; Elsenbruch et al., 2003) . A meta-analysis showed that PCOS patients' mental health problem and emotional problem (depression, stress and anxiety) scores are lower than those of healthy women, and these psychosocial factors may promote certain behaviors (such as overeating and alcoholism) that disrupt endocrine system function and thus worsen PCOS symptoms (Hayashi et al., 2011) . These studies focused only on the psychological effects of hormonal changes and body surface changes in patients with PCOS. Eggers et al. suggested that PCOS is not only a medical problem but also a psychosocial problem. Infertility, hairiness and obesity of PCOS patients can increase the psychological stress of these patients (Eggers and Kirchengast, 2001) . However, many questions, such as how psychological factors participate in PCOS development, how stress-related stress and immune mechanisms are involved, how various factors affect each other, and how many factors affect the endocrine system, still need to be answered in the context of psychology, epidemiology and other aspects of obstetrics and gynecology. Basic medical research should be performed to answer these questions.
(6) Summary Despite substantial efforts to explore the cause of PCOS in past decades, the interrelationships among genetic, epigenetic and environmental factors in the pathophysiology of PCOS are far from clear. It is likely that a more comprehensive understanding of the underlying molecular mechanisms of PCOS will facilitate the diagnosis and improve the treatment of this complicated syndrome.
Etiologies of male infertility
Approximately 10%-15% of cou ples of reproductive age have infertility problems, and approximately 50% of these couples experience male infertility (Agarwal et al., 2015) . The etiology of male infertility is varied. The different causes of male infertility can be generally categorized into three groups: pretesticular, testicular and posttesticular causes (Cocuzza et al., 2013) . Pretesticular causes are endocrine abnormalities associated with alteration of the hypothalamicpituitary-gonadal axis that lead to failure of the Sertoli and Leydig cells to support spermatogenesis. Testicular causes are intrinsic disorders of spermatogenesis. Posttesticular causes include blockage of the male reproductive tract, generally with preservation of normal spermatogenesis. Azoospermia, which is the complete absence of sperm in the ejaculate, occurs in 10%-15% of infertile men or approximately 1% of all men. Posttesticular azoospermia is termed obstructive azoospermia, and testicular and pretesticular azoospermia are jointly termed nonobstructive azoospermia (NOA).
Both genetic and nongenetic factors can lead to male infertility. Varicoceles, undescended testes, urogenital infections and gonadotoxins are common nongenetic causes of male infertility (Punab et al., 2016; Tuttelmann et al., 2011b) . Known genetic causes include Klinefelter's syndrome and Y chromosome microdeletion for the NOA and cystic fibrosis transmembrane conductance regulator (CFTR) mutations for obstructive azoospermia (Krausz and Riera-Escamilla, 2018) . However, with current diagnostic methods, the causes of azoospermia and severe oligozoospermia (SO) remain unable to be identified in approximately 40% of men, and these patients receive a diagnosis of idiopathic infertility. Because inadequate assessment of the causes of male infertility often results in the performance of expensive assisted reproductive technology (ART) procedures associated with high morbidity in the female partner, a better understanding of the etiology of male infertility is urgently needed.
Epidemiology of infertility with common known genetic causes and idiopathic infertility
The current genetic analysis methods for male infertility mainly include karyotype analysis for detection of chromo-somal aberrations, including Klinefelter syndrome and Y chromosome microdeletion screening, and mutation screening for a few genes, including CFTR (Krausz and Riera-Escamilla, 2018) . Klinefelter syndrome is due to an extra X chromosome (47, XXY), and it is the most common genetic cause of azoospermia. Other chromosome abnormalities, including Robertsonian translocations and inversions, can also lead to male infertility. Y chromosome microdeletion is due to deletion of the azoospermia factor (AZF) regions on the long arm of the Y chromosome (Yq11), which is the most frequent molecular genetic cause of NOA and SO. The CFTR gene is frequently mutated in Caucasians, and recessive mutations can lead to ductal obstruction and congenital absence of the vas deferens (CAVD) with normal renal anatomy. Additionally, congenital hypogonadotropic hypogonadism, including Kallmann syndrome, which is a complex genetic disease caused by congenital abnormality in the hypothalamic-pituitary-gonadal axis, leads to pretesticular male infertility. Excellent reviews of these frequently known genetic causes of male infertility have been presented elsewhere (Krausz and Riera-Escamilla, 2018) .
Two recent large-scale epidemiological studies have provided comprehensive overviews of the etiology of male infertility. One study, a country-wide monocenter study, prospectively analyzed 1,737 patients with severe male factor infertility (Punab et al., 2016) . Another study retrospectively investigated 1,583 azoospermic patients over a period of 30 years (Tuttelmann et al., 2011b) . In total, genetic abnormalities were identified in approximately 21%-25% of azoospermia patients, 10% of cryptozoospermia patients, 2.5% of SO patients and 1% of oligozoospermia patients. Thus, the genetic risk of male infertility increased with decreasing sperm output by an infertile man, and an azoospermia patient was more likely to suffer from genetic abnormalities than an oligozoospermia patient. Klinefelter syndrome, Y chromosome microdeletion and other chromosomal aberrations accounted for approximately 15%, 2%-6%, and 1% of azoospermia cases, respectively. While all patients with Klinefelter syndrome were azoospermic, patients with Y chromosome microdeletion and other chromosomal aberrations could be azoospermic or exhibit less severe dysfunction. Among 40 patients with Y chromosome microdeletion, 11 (28%) and 4 (10%) exhibited cryptozoospermia and oligozoospermia, respectively, which is consistent with the findings of previous studies (Simoni et al., 2008) CFTR mutation and congenital hypogonadotropic hypogonadism account for approximately 3% and 1%-2% of the cases, respectively.
The percentages of patients with idiopathic azoospermia with no identifiable causes were 12% and 17.3% in these two studies, respectively. The percentages of patients with idiopathic cryptozoospermia and SO were dramatically higher at 58.5% and 73.9%, respectively. In total, approximately half (53.4%) of allazoospermia, cryptozoospermia and SO cases were diagnosed as idiopathic.
Familial NOA and SO Large families greatly facilitate localization of a dominant trait and identification of the underlying genetic causes. However, since infertile men do not reproduce, genetic studies on male infertility are difficult. Consanguineous families are a precious resource. Recent studies on large consanguineous families using powerful genomic technologies have been fruitful for identifying the underlying genetic causes of male infertility. A study by Ayhan et al. is a typical example (Ayhan et al., 2014) . The authors analyzed two unrelated large consanguineous families. In family 1, four of the eight brothers had reduced sperm levels, three with azoospermia and one with oligozoospermia. In family 2, three azoospermic brothers suffered from maturation arrest at the spermatid stage. The disease gene regions were first localized by genotyping and linkage analysis, and then one azoospermic man in each family was subjected to wholeexome sequencing. For family 1, a nonsense mutation of TAF4B was found that was deduced to truncate the protein product of the gene. For family 2, an exonic deletion of four nucleotides of ZMYND15 was found that was deduced to shift the translational reading frame. Since both mutations were deleterious and since mouse KO models had spermatogenesis defects, the authors concluded that these two mutations underlay the disorder in the families.
Dozens of candidate genes, including TAF4B, ZMYND15, SYCE1, TEX15, NPAS2, MCM8, and TDRD9, have been identified using consanguineous families (Arafat et al., 2017; Avenarius et al., 2009; Ayhan et al., 2014; Colombo et al., 2017; Gershoni et al., 2017; He et al., 2018; Kherraf et al., 2017; Maor-Sagie et al., 2015; Okutman et al., 2015; Okutman et al., 2017; Ramasamy et al., 2015; Riera-Escamilla et al., 2019; Tenenbaum-Rakover et al., 2015) (Table 5 ). The discovery of these candidate genes confirms the notion that human male infertility can be caused by mutations in a large number of spermatogenesis-related genes with conserved functions in mice (Aston and Carrell, 2009) .
Sporadic NOA and SO
The vast majority of infertility cases are nonfamilial. Although consanguineous family-based studies can identify novel candidate genes, they provide limited insights into sporadic male infertility, which is characterized by more complexity and genetic heterogeneity than familial male infertility. GWASs are powerful genomic approaches for investigating complex genetic diseases. Over the last few years, six GWASs have been performed in idiopathic infertile cohorts. However, although these studies have identified several variants that are significantly associated with male infertility, the identified genomic regions have rela-tively low effect sizes and do not overlap (Aston and Carrell, 2009; Aston et al., 2010; Dalgaard et al., 2012; Hu et al., 2014; Hu et al., 2012; Zhao et al., 2012) . Additionally, a recent study that analyzed 654 infertility-related genes in NOA patients through targeted sequencing found no candidate genes or variants individually showing significant association with NOA .
A number of studies have used the single candidate gene resequencing approach. For some genes, including NR5A1, SYPC3, KLHL10, SLC26A8, SOHLH1, WT1 and NA-NOS1, researchers have found heterozygous mutations present at low frequencies in infertile cohorts and absent from controls (Table 5 ) (Bashamboo et al., 2010; Choi et al., 2010; Dirami et al., 2013; Ferlin et al., 2015; Foresta et al., 1999; Gou et al., 2017; Kasak et al., 2018; Kusz-Zamelczyk et al., 2013; Lopes et al., 2013; Ma et al., 2016a; Miyamoto et al., 2016; Miyamoto et al., 2003; Mozdarani et al., 2018; Nakamura et al., 2017; Riera-Escamilla et al., 2019; Ropke et al., 2013; Yang et al., 2015; Yatsenko et al., 2015; Yatsenko et al., 2006; Zare-Abdollahi et al., 2015) . Although the results of most of these studies still need to be independently validated, NR5A1 is an interesting candidate gene that has been reported by several different groups. Since 2010, four groups have independently reported NR5A1 mutations in NOA and SO patients (Bashamboo et al., 2010; Ferlin et al., 2015; Ropke et al., 2013; Zare-Abdollahi et al., 2015) . The mutation frequencies reported by the four groups were 0.4%, 2.2%, 3.1% and 3.9% in NOA patients. All the identified mutations are heterozygous missense mutations, and most of them have been shown to have reduced transactivation ability in cultured cell lines (Bashamboo et al., 2010; Ferlin et al., 2015) . Although no mutations were found in the examined fertile controls, many variants were present in multiple individuals with allele frequencies of up to 0.3% in certain populations in the Exome Aggregation Consortium (ExAC) database (n=60,706). These findings suggest that these heterozygous missense mutations alone are not sufficient to cause infertility but that they do increase disease risk.
Most potential disease-associated mutations identified in sporadic NOA and SO have been heterozygous missense mutations, the functional importance of which is not straightforward. A few studies have functionally validated the mutations in mouse models (Gou et al., 2017; Yang et al., 2015) . Gou et al. screened the D-box region of the Hiwi gene and identified three heterozygous missense mutations in 3 out of 413 idiopathic azoospermia cases, while none were present in controls (Gou et al., 2017) . The authors had previously shown that the D-box region, which is conserved among vertebrate genes including HIWI in humans and MIWI in mice, is essential for ubiquitination and degradation of MIWI in late spermiogenesis. They constructed a conditional knock-in mouse model and transgenic mice with one of the three mutations in the MIWI gene. The mice carrying this heterozygous missense mutation were sterile, indicating that the mutation had dominant effects causing male sterility. Mechanistically, the authors showed that the mutation impaired HIWI ubiquitination and resulted in stabilization and accumulation of mutant HIWI protein, which sequestered RNF8 in the cytoplasm and then caused defects in histone-toprotamine exchange. This study showed the value of modeling potential disease-associated mutations in vivo for functional validation and dissection of molecular mechanisms.
TEX11 is mutated in 1% of azoospermia patients
The most successful exploration of causal mutations for idiopathic male infertility revealed TEX11, which is located on the X chromosome. In 2015, two groups independently identified TEX11 as a recurrent causal gene for NOA Yatsenko et al., 2015) . Yatsenko et al. initially used a genome-wide array comparative genomic hybridization (aCGH) microarray to analyze 15 men with azoospermia and identified one patient with a 90 kb hemizygous deletion spanning exons 10, 11 and 12 of TEX11 (Yatsenko et al., 2015) . Then, they sequenced TEX11 in 48 men with azoospermia and identified one patient with a missense mutation and another patient with an absence of PCR products for a region spanning exons 10, 11 and 12, which was confirmed to result from the same hemizygous deletion as that of the first patient. Next, examination of 240 men with azoospermia identified three splicing mutations and one missense mutation. The missense mutation and one of the three splicing mutations were found in the Single Nucleotide Polymorphism Database (dbSNP) at frequencies of 0.1%-0.2%, not supporting a dominant effect. Thus, LOF mutations occurred in 1.3% (4 of 289) of azoospermia patients.
In another study, Yang et al. sequenced TEX11 in 246 azoospermic men with spermatogenic failure and 175 controls . They identified 21 singleton variants, 18 in azoospermic men and three in controls. Thus, the prevalence of singleton variants is significantly higher in azoospermic men than in healthy men. Among the 18 singleton variants in azoospermic men were one frameshift mutation, one splice site mutation and five missense mutations. Thus, LOF mutations occurred in 0.8% (2 of 246) of this cohort of azoospermia patients and in 1.1% (6 of 535) of all azoospermia patients in these two studies. None of the six LOF mutations were found in controls or in the ExAC database, providing strong evidence that these are causal mutations.
Testis biopsy results were obtained for five of the six patients with LOF mutations. Notably, the results for four of the patients revealed meiotic arrest, while one showed mixed testicular atrophy; mutations in TEX11 were identified in as many as 15% of patients with meiotic arrest. This finding is consistent with the phenotype of meiotic arrest for Tex11 knockout mice.
Together, these findings indicate that hemizygous mutations in TEX11 are the only single-gene defects with sufficient evidence to be considered direct causes of sporadic azoospermia.
Copy number variants (CNVs) in NOA and SO
CNVs are a type of structural variation in which sections of the genome are repeated or deleted. Many CNVs have been shown to make significant contributions to a number of complex human genetic diseases, such as autism spectrum disorders, intellectual disability and cardiac defects (Riggs et al., 2014) . Six studies have reported CNV analyses in men with NOA and SO, four of which included relatively large numbers of patients Krausz et al., 2012; Lo Giacco et al., 2014; Lopes et al., 2013; Stouffs et al., 2012; Tuttelmann et al., 2011a) . These studies consistently found that the sex chromosomal CNV burden is higher in patients than in controls. Tuttelmann et al., for the first time, analyzed 89 men with SO, 37 men with Sertoli cell-only syndrome and 100 controls using genome-wide aCGH (67). Their results revealed that sex chromosomal CNVs were (Foresta et al., 1999; Mozdarani et al., 2018) DAZ2 Sporadic Hemizygous microdeletion (Foresta et al., 1999; Mozdarani et al., 2018) DAZ3 Sporadic Hemizygous microdeletion (Foresta et al., 1999; Mozdarani et al., 2018) DAZ4 Sporadic Hemizygous microdeletion (Foresta et al., 1999; Mozdarani et al., 2018 (Ramasamy et al., 2015) NR5A1 Sporadic Heterozygous missense (Bashamboo et al., 2010; Ferlin et al., 2015; Ropke et al., 2013; Zare-Abdollahi et al., 2015) PLK4
Sporadic Heterozygous frameshift (Miyamoto et al., 2016) RNF212 SYCP3 Sporadic Heterozygous truncation (Miyamoto et al., 2003) TAF4B Consanguineous familial Homozygous nonsense (Ayhan et al., 2014) TDRD9 Consanguineous familial Homozygous frameshift (Arafat et al., 2017) TEX11 Sporadic Hemizygous deletion, frameshift, splice and missense Yatsenko et al., 2015) TEX14 Consanguineous familial Homozygous frameshift TEX15
Consanguineous and nonconsanguineous familial
Homozygous nonsense; compound heterozygous nonsense/premature stop codons (Colombo et al., 2017; Okutman et al., 2015) USP26 Sporadic Hemizygous missense (Ma et al., 2016a) ZMYND15 Consanguineous familial Homozygous frameshift (Ayhan et al., 2014) significantly overrepresented in patients with Sertoli cellonly syndrome. Krausz et al. analyzed 96 men with NOA/SO and 103 controls using customized aCGH covering the X chromosome (Krausz et al., 2012) . They found that the patients had significantly higher burdens of X chromosome CNV deletion with regard to both number and size compared with the controls. Lopes et al. analyzed a total of 323 men with NOA and SO and 1,100 controls (Lopes et al., 2013) . Their results showed that the burdens of rare CNVs (CNVs with a call frequency of less than 5%) on the X chromosome (gain or loss) and Y chromosome (gain) and autosomal deletion were higher in the patients than in the controls. Huang et al. analyzed SNP array data of 970 Han Chinese men with idiopathic NOA and 1,661 controls that was initially used for a GWAS and showed a significant excess of CNV events on the X chromosome (gain and loss) and Y chromosome (loss) in patients . Singleton Y-linked duplications and singleton autosomal deletions were more frequent in cases than controls, but the differences were not significant or were only marginally significant. Together, these data are largely consistent, and an association between X chromosomal deletion and NOA has been reported by all these studies. Duplication and deletion of the Y chromosome, duplication of the X chromosome, and CNVs in autosomes appear to be relatively modestly enriched in NOA patients. Recurrent patient-specific CNVs have been identified as candidate loci for increased risk of male infertility. Notably, TEX11 was initially identified as an X chromosomal deletion by using aCGH (Yatsenko et al., 2015) . Regarding other interesting loci, deletions of DMRT1, which is a gene on chr9p24.3, were found to occur at frequencies of 0.38% in a total of 1,306 cases and 0% in 7,754 controls in data from several cohorts (Dirami et al., 2013) . CNV67, which is a deletion of Xq28, was observed in 4 (1.1%) of 359 patients and none of 370 controls (Lo Giacco et al., 2014) . Duplication of MAST2 located at 1p34.1was observed in 11 of 1,457 patients and 1 of 1,590 controls .
ScRNA-seq for azoospermia
The rapid development of scRNA-seq technologies has provided a new opportunity for exploring the etiology of idiopathic male infertility. The testis biopsy is the basic laboratory test for evaluating a primary testicular failure patient. Testis histology varies among patients, and azoospermia can present as Sertoli cell-only syndrome, spermatogenic arrest at different stages, or hypospermatogenesis. However, routine histological examination is not able to explore the etiology in depth. ScRNA-seq can comprehensively profile the gene expression characteristics of each cell type and subtype at single-cell resolution and thus provide clues to the cause of the disease. Among several recent scRNA-seq studies on human adult spermatogenesis, one study analyzed an NOA case . ScRNA-seq analysis of 174 cells in the testicular tissue of the patient identified only Sertoli and supporting cells, which was consistent with the histological results. Interestingly, a comparison between the supporting cells from the patient and those from normal individuals identified a set of genes that were upregulated in the supporting cells from the patient; the enriched genes were potentially associated with male reproduction (e.g., INHA, FATE1 and BEX1) as well as oxidative stress and DNA damage responses. The γH2AX signal accumulated in the testicular somatic cells of the patient, further supporting the presence of the DNA damage response in these cells. Although more cases need to be studied, this study showed that scRNA-seq technology provides a new perspective and platform for exploring the causes of idiopathic infertility. In the future, larger cohorts of patients are needed, and single-cell epigenome sequencing and proteomic profiling technologies will also help dissect the disease from multiple omics levels.
Disease modeling using in vitro male germ cell development
Reconstitution of male germ cell development and production of functional sperm in vitro should provide a system for investigation of the genetic, epigenetic, and environmental etiologies of azoospermia. As mentioned above, recent studies have efficiently generated human and mouse PGC-like cells from pluripotent stem cells in vitro (Hayashi et al., 2011; Irie et al., 2015; Sasaki et al., 2015) . Notably, mPGCLCs can generate sperm with healthy offspring after transplantation into testes (Hayashi et al., 2011) . In a more recent study, Zhou et al. cocultured mPGCLCs with neonatal testicular somatic cells and sequentially added morphogens (activin A, bone morphogenetic proteins (BMPs), and RA) and sex hormones (FSH, bovine pituitary extract and testosterone). The authors showed that this culturing system can promote mPGCLCs to enter meiosis and ultimately form spermatids with an efficiency of 14%-20% .
Another fundamental cell type includes SSCs, which are capable of self-renewal for long-term maintenance of adult spermatogenesis. Mouse in vitro-cultured SSCs are quite stable and can be cultured for more than 2 years (Kanatsu-Shinohara and Shinohara, 2013) . Human SSCs can be successfully cultured and expanded in vitro; even though they are not as stable as mouse SSCs, culturing times of up to 28 weeks have been reported (Sadri-Ardekani et al., 2009) . Cultured human SSCs have also been reported to generate spermatids with various efficiencies (Galdon et al., 2016) . Thus, it is also possible to induce hPGCLCs to form SSCs for reconstitution of the whole male germ cell developmental process.
Together, this evidence of recent progress on in vitro gametogenesis highlights the possibility of establishing a pa-tient-specific disease model of azoospermia.
Emerging technologies in reproductive biology
Gene editing
Principle of gene editing
In gene editing, a target gene is modified through knockout or insertion of specific DNA fragments. Gene editing mostly relies on the generation of DNA double-strand breaks (DSBs) (Chang et al., 2017; Lieber, 2010; Lieber and Karanjawala, 2004; Martin et al., 1985) . Cells can be repaired in a variety of ways after DSBs form, mainly nonhomologous end joining (NHEJ) and homologous recombination (HR) (Chang et al., 2017) . HR can repair DNA without errors but requires the presence of a homologous template (Hartlerode and Scully, 2009; Paques and Haber, 1999; Sung and Klein, 2006) . NHEJ directly connects two DNA ends that are largely nonhomologous, and this repair method easily leads to mutations and KO of genes (Lieber et al., 2003; Sung and Klein, 2006) . Based on the principle of DNA repair, if a specific HR template is artificially provided in a cell and DSBs naturally occur or are artificially induced in the target DNA, triggering HR, there is an opportunity to delete a specific DNA sequence or insert foreign DNA. Traditional gene editing involves targeted integration by means of naturally occurring DSBs in cells to achieve gene KO and replacement (Capecchi, 1989) . However, in eukaryotic cells, the probability of achieving target gene editing by spontaneous DSBs is typically as low as one in a million (Capecchi, 1989; Chandrasegaran and Carroll, 2016) . GMs can also be achieved using artificial inducers, radiation treatments or transposon technology, but the resulting mutations are random and require extensive screening to obtain the desired genotype. Targeted gene editing technologies developed in recent years are the preferred tools for genetic function research and species-oriented transformation.
Commonly used gene editing technologies
(1) Zinc finger (ZF) nucleases (ZFNs) The development of artificial nuclease technologies has made targeted DSB induction a reality. In particular, the development of ZFN technology, also known as the first generation of gene editing technology, was a major breakthrough. Each ZFN is composed of a ZF protein (ZF protein, ZFP) and the Fok I endonuclease domain of the enzyme; the former is responsible for identification, and the latter is responsible for cleavage of DNA. ZFP is a naturally existing protein structure composed of zinc (a ZF); the ZF can recognize 3 consecutive base pairs, and the recognition specificity of a ZFN can thus be adjusted via a series of different numbers of ZFs (Chandrasegaran and Carroll, 2016; Remy et al., 2010) . Fok I is connected to the ZFP through the N-terminus. Since Fok I performs its editing role as a dimer, the ZFN structure needs to be paired to be active (Remy et al., 2010) . As a new gene editing tool, ZFN technology has been used for gene editing in different species since 2001 (Bibikova et al., 2001; Carroll, 2011; Remy et al., 2010) .
(2) Transcription activator-like effector (TALE) nucleases (TALENs) ZFN technology propelled gene editing into an era in which the procedure no longer relied solely on naturally occurring DSBs. However, this technology has many limitations, such as its high cost and difficulty in achieving multitarget editing. With the discovery of the TALE motif, a second generation of gene editing technology involving TALENs (Chandrasegaran and Carroll, 2016; Joung and Sander, 2013; Sakuma and Yamamoto, 2017) has emerged.
The structure of a TALEN is similar to that of a ZFN. The TALE motif is cascaded into a DNA recognition module that determines the targeting motif and is linked to the Fok I domain (Chandrasegaran and Carroll, 2016) . Unlike the ZF motif, the TALE motif recognizes a base pair, and the tandem TALE motif has a one-to-one correspondence with the identified base pair. A previous study found that TALENs have the same editing efficiency as ZFNs at the same target, but the toxicity of TALENs is usually lower than that of ZFNs, and it is also easier to construct TALENs than ZFNs (Bibikova et al., 2001) . However, TALENs are much larger and contain more repeats than ZFNs, and the coding genes of TALENs are more difficult to assemble in E.coli (Sakuma and Yamamoto, 2017) .
(3) Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 technology and its derivatives Thirty years ago, experimental biologists stumbled upon a group of repeated palindromes when analyzing a gene in a bacterium that colonized the human gut (Lander, 2016) . Such "passwords" were then found in other bacterial genomes (Lander, 2016) . Meticulous calculation by biologists revealed that this type of password is a key means for bacteria to resist invasion by foreign enemies (Ishino et al., 1987) . This result was subsequently confirmed by experimental biologists at a yogurt factory (Mojica et al., 1995) . A few years later, such passwords began to be exploited, triggered explosive progress in the field of gene editing (Lander, 2016; Mojica et al., 2000) . These clustered, regularly spaced, short palindromes and repetitive sequence ciphers were named CRISPRs (Jansen et al., 2002) .
As the newest genetic editing technology in life sciences, CRISPR editing has excited researchers because of its high efficiency, convenience and widespread applicability (Jiang and Doudna, 2017; Musunuru, 2017) . Its applicability has also promoted progress in basic research, agriculture, basic medicine and clinical treatment (Huang et al., 2017b; Minkenberg et al., 2017; Saayman et al., 2015) .
(4) The CRISPR/Cas9 technique The CRISPR/Cas system was originally an adaptive immune system in which bacteria and archaea evolved to resist foreign viruses and plasmid DNA. The type II CRISPR/Cas system relies on the integration of foreign DNA fragments into regularly clustered short-interval palindromes that are transcribed and cleaved to produce short CRISPR RNAs (crRNAs), which then bind to transactivating crRNAs (tracrRNAs) and the Cas9 guide protein to mediate sequence-specific exogenous DNA degradation (Chandrasegaran and Carroll, 2016; Horvath and Barrangou, 2010; Mali et al., 2013a; Nishimasu et al., 2014) . The crRNA and tracrRNA on which Cas9 depends for targeted cleavage can be fused together as single guide RNA (sgRNA) (Jinek et al., 2012) . Several research groups have reported that the CRISPR/Cas9 system can be used for targeted gene editing in human cells (Cho et al., 2013; Cong et al., 2013; Jinek et al., 2013; Mali et al., 2013b) . Compared to ZFN and TALEN technology, CRISPR/Cas9 technology is designed to be much simpler and less expensive, and for the same target, CRISPR/Cas9 has comparable or even better targeting efficiency (Mali et al., 2013a) .
(5) CRISPR/Cas9-nickase To improve the accuracy of the Cas9 editing system, scientists have skillfully utilized the Cas9 D10A mutant, which has nicking enzyme activity, and designed a one-site dual-sgRNA targeting strategy named CRISPR/Cas9-nickase gene editing technology . The principle is similar to that of the ZFN and TALEN technologies. Two Cas9n/sgRNA complexes simultaneously target one site and cleave one of the DNA strands to make DSBs and induce NHEJ or HR repair . Using this strategy, the accuracy of gene editing in cell lines has been effectively improved.
(6) CRISPR/dCas9-FoKI To increase the accuracy of CRISPR/Cas9 technology, Guilinger et al. adopted a dCas9-based strategy (Guilinger et al., 2014) . In theory, dCas9/sgRNA can play only a simple targeting role and cannot induce DNA fragmentation, similar to the DNA-binding domains in ZFNs or TALENs. To enable DNA cleavage, an introduced cleavage domain of Fok I endonuclease was ligated with dCas9 to form the fusion protein fCas9, similar to the design strategy for ZFNs and TALENs. For gene editing in human cells, fCas9 demonstrates more than 140-fold higher specificity than wild-type Cas9 (Guilinger et al., 2014) . At a highly similar target site, fCas9 is at least four fold more specific than Cas9n. The application of fCas9 further expands the Cas9 toolbox and provides a more complete set of genetic editing tools.
(7) Base editing based on CRISPR/dCas9 Most human genetic diseases are related to point mutations in genes; precise repair of these mutations may enable the development of new therapeutic strategies. Site-directed mutagenesis can be achieved by CRISPR/Cas9to provide a HR template, but random insertions and deletions of bases that may be induced by NHEJ repair are potential risk factors. The Cas9 mutants Cas9n and dCas9 lack the ability to cleave double-stranded DNA but can perform targeting functions. As long as a protein or domain can catalyze a specific base conversion, CRISPR/Cas9n/dCas9-directed base editors can be constructed. Liu's group fused cytosine deaminase (APOBEC1) derived from rats to dCas9 and found that this construct could convert C to U at a fixed point and then induce a C:G to T:A base pair conversion during subsequent DNA replication or repair (Komor et al., 2016) . Shortly after, the Kondo group from Kobe University in Japan and the Changxing group from Shanghai Jiaotong University in China also reported similar research results (Ma et al., 2016b; Nishida et al., 2016) . To induce the conversion of A:T to G:C, Liu's group used evolutionary engineering of proteins to transform the tRNA adenosine deaminase (TadA) of E. coli and obtained a 7th-generation adenine base editor (ABE) to efficiently mediate this conversion (Gaudelli et al., 2017) . In summary, free conversion between C and T and between G and A bases has been achieved, and it will be possible to perform arbitrary conversion among four bases in the future.
(8) CRISPR/Cas12a for RNA editing In addition to editing DNA, Feng Zhang found that the CRISPR protein family C2c2 (now called Cas13a) can induce RNA cleavage (Abudayyeh et al., 2016) ; these authors subsequently confirmed that Cas13a can target RNA and reduce RNA levels in mammalian cells . Through the use of the RNA-targeting function of Cas13a, a CRISPR/Cas13a RNA detection system has been developed for disease diagnosis . Feng Zhang's team later discovered Cas13b, which also has RNA-targeting and RNA-editing capabilities (Smargon et al., 2017) . In addition, Cas13c and Cas13d have similar functions (Yan et al., 2018) . The establishment of RNA editing technology further expands the application range of CRISPR/Cas gene editing technology.
Risks of genetic editing technology
(1) Gene editing efficiency Compared to conventional methods, the CRISPR/Cas9 system has effectively improved the efficiency of gene editing; however, the editing efficiency still cannot be guaranteed to be greater than 50%, and the editing windows and mutation types also demonstrate randomness (Bannikov and Lavrov, 2017; Men et al., 2017) . However, treatments for many diseases, such as HIV, must produce mutations in both copies of a gene (CCR5 for HIV) to achieve therapeutic goals Liu et al., 2017b; Xu et al., 2017b) . Therefore, for gene editing technology to be used for clinical purposes, further improvement in editing efficiency is critical.
(2) Off-target effects Since the advent of gene editing technologies, the offtarget risks of these methods have received much attention (Tasan and Zhao, 2017) . Although the specificity of Cas9 is considered to be closely controlled by sgRNA, off-target effects may still occur at genomic regions adjacent to the target site or at positions with similar sequences as the target site (Tsai and Joung, 2016) . These off-target effects may lead to genomic instability and disrupt normal cell function and may even induce the development of cancer, which is the main concern related to the clinical application of gene editing systems (Knott and Doudna, 2018) . Scientists have introduced in vitro assays and a variety of off-target detection protocols relying on either computer software predictions or high-throughput sequencing to detect DSB production (Anderson et al., 2018; Kim et al., 2017; Lazzarotto et al., 2018; Tsai and Joung, 2016) . These methods have some limitations, and it is not possible to detect off-target mutations, especially single-nucleotide mutations, with high sensitivity.
Whether the CRISPR/Cas9 system and its derivatives exert off-target effects has been controversial and has also caused great hesitation regarding their clinical application. Therefore, developing an off-target detection method that can overcome the previous limitations will be key to improving the clinical utility of these methods.
In 2019, Hui Yang's team established an off-target detection technology called Genome-wide Off-target analysis by Two-cell embryo Injection (GOTI) (Zuo et al., 2019) . When a fertilized mouse egg splits at the two-cell stage, the blastomere is edited and labeled with a red fluorescent protein.
After the mouse embryo has developed for 14.5 days, the entire embryo is digested into single cells. By fluorescenceactivated cell sorting (FACS) based on red fluorescent protein, the genetically edited cells and nonedited cells can be sorted. Then, whole-genome sequencing (WGS) is conducted on the DNA, and the differences between the two groups are analyzed based on the WGS data. This method avoids the noise problem caused by the in vitro expansion of single cells. Because the experimental and control groups are from the same embryo, they theoretically have exactly the same genetic background. Therefore, the differences between the genomes of the two cells can be considered to have been caused by the editing tools. With the help of this system, the team first tested the classic CRISPR/Cas9 system and found that a well-designed CRISPR/Cas9 method did not have obvious off-target effects. This result ended the previous controversy over the potential off-target effects of CRISPR/Cas9. The team also tested another CRISPR/Cas9derived technology, the BE3 system, which was also highly anticipated. This system can accurately introduce point mutations, and no significant off-target problems have been found in several previous studies (Cornu et al., 2017; Gaudelli et al., 2017; Rees and Liu, 2018) . However, GOTI re-vealed a very severe off-target issue associated with the BE3 system, and most of the off-target effects appear at sites unlikely to be detected by traditional off-target prediction methods, explaining why the off-target problem has not been found in other studies . It is believed that some of these off-target sites appear on the tumor suppressor gene, so the classic version of the BE3 system presents great risk and is not suitable for clinical technology at present. Offtarget detection based on GOTI technology indicates that there is unpredictable off-target risk for some gene editing techniques associated with BE3. These findings have encouraged scientists to develop next-generation gene editing tools that are safer and more accurate.
At the same time, scientists have been working to reduce or even eliminate off-target effects. The first and most common method involves altering the sequence of the sgRNA, such as shortening the 3′ end of sgRNA or increasing the number of guanines at the 5′ end, which can significantly improve specificity Fu et al., 2014) . In addition, there are tens of millions of "seed+NGG" sequences in the genome, but only less than one percent of these are found in enhancers, promoters and genes, so designing sgRNAs for these areas can also significantly reduce off-target effects (Wu et al., 2014) . The second method involves controlling the amounts of Cas9 and sgRNA used to find doses that will ensure adequate targeting efficiency without producing off-target effects (Fu et al., 2013; Kuscu et al., 2014) . A third method involves improving the protein; introducing Cas9 D10, which only induces mutation in one strand of DNA, or introducing point mutations on Tad or APOBEC1 of base editors can effectively reduce the offtarget effects of DNA or RNA (Grunewald et al., 2019; Gu et al., 2019; Kim et al., 2019) .
Application of gene editing techniques in gene therapy
(1) Application of gene editing technology in hematopoietic stem cells (HSCs)
As the CRISPR/Cas9 system precisely modifies the development of the human genome, it has been applied to HSCs (Callaway, 2016) .
Genome editing technology has evolved. HSCs are easily separated and highly differentiated and exhibit self-renewal, making them clinically promising (Antoniani et al., 2017) . HSC or progenitor cell transplantation enables the replacement of part or all of a patient's bone marrow with donor cells to treat congenital or hereditary diseases, including blood, immune and metabolic disorders/diseases (Dever and Porteus, 2017) . In some cases, genetically engineered HSCs have successfully established mid-and long-term reconstitution of the blood system in patients, greatly ameliorating graft-versus-host-related adverse effects as well as transcriptional and delivery vector-related genomic perturbations (Jafarian et al., 2019; Schiroli et al., 2019) . For example, thalassemia is caused by imbalance between alpha and beta globin chains; excess amounts of free alpha globin chains cause the body to produce ineffective red blood cells and cause hemolysis. Mettananda et al. found that when alpha thalassemia is coinherited with beta thalassemia, the levels of free alpha globin chain are significantly reduced, which reduces the severity of the disease (Mettananda et al., 2015) . A study using CRISPR/Cas9 to edit primary human CD34 + cells revealed that simulation of naturally occurring deletions of MCS-R2 (an alpha globin enhancer) could further cause thalassemia. Knocking out MCS-R2 in the CD34 + cells of beta Mediterranean anemia had no effect on differentiation capacity but reduced the expression of alpha globin and successfully corrected the pathological imbalance of globin chains with no evident off-target effects (Mettananda et al., 2017) . The researchers also found that a certain percentage of long-term HSCs existed among the edited CD34 + cells, indicating that the method has great potential for the treatment of thalassemia (Mettananda et al., 2017) . Genetically edited HSC autograft protocols have been conducted in a number of clinical trials. Developing CRIPSR/Cas9 systems with high efficiency and safety and applying them for the treatment of HSC-related diseases is a long-term goal in the field of genetic editing .
(2) Application of gene editing technology for human embryo editing Given its successful application in multiple species and multiple fields, gene editing technology has inevitably also been applied in humans (Callaway, 2016) . According to its object, such editing can be divided into somatic gene editing and germ cell gene editing (Ishii, 2017) . The editing of somatic cells is mainly used to treat diseases, such as enhanced tumor immunotherapy (Cooper et al., 2018) . Gene editing also has great potential in human germ cells because early embryonic development is somewhat different in humans than in model animals such as mice (Petropoulos et al., 2016) . Some human early embryonic development problems can be investigated only in human embryos (Cyranoski and Reardon, 2015) . In addition, more than 10,000 genetic diseases have been discovered, and these genetic diseases are expected to be effectively treatable by genetic editing techniques Niederberger, 2018) . Currently, only approximately 6% of genetic disorders among the more than 10,000 kinds of genetic diseases have been reported to be effectively treated (Austin and Dawkins, 2017) . Due to its target ability and high efficiency, gene editing technology shows considerable potential for the treatment of human genetic diseases . In April 2015, Huang et al. from Sun Yat-sen University published a report of the first use of CRISPR/Cas9 for human embryonic gene editing . The results showed that CRISPR/Cas9 efficiently cleaved the endogenous HBB gene in human triploid-pronucleus (3PN) embryos, and cleavage success-fully occurred in 28 of 54 embryos, with an efficiency of 52%. However, only 4 of the 28 edited embryos exhibited exact repair through HR, which represents an efficiency of only 15%, and a significant off-target effect was found in the edited embryo. The emergence of this research has caused tremendous repercussions in the academic world and has led to extensive discussions on the editing of human embryonic genes (Cyranoski and Reardon, 2015; Gross, 2015; Porteus and Dann, 2015) . In April 2016, Yong Fan's team from the Third Affiliated Hospital of Guangzhou Medical University knocked out the CCR5 gene in 3PN human embryos. They used CRISPR/Cas9 to achieve precise KO of 32 bases of theCCR5 gene by HR and found that HR occurred in only one of 20 embryos, with an efficiency of only 5% (Kang et al., 2016) . The authors also used two sgRNAs to knock out the 32 nucleotides and found that 4 out of 26 resulting embryos exhibited accurate KO of the 32 nucleotides, resulting in an efficiency of approximately 15% (Kang et al., 2016) . The above results preliminarily indicated that HR efficiency in human embryos is relatively low. If the targeting sites of two sgRNAs can be rationally designed, the efficiency of editing will be higher than that of HR. In August 2017, Liu et al. issued a report on two-locus editing in diploid-pronucleus (2PN) embryos . They edited the site4 and RNF2 genes in HEK293T cells by microinjection of abase editing system and found that for site 4, seven out of eight embryos were efficiently edited. High-throughput sequencing of three of these embryos revealed that the C5 site was 100% edited, demonstrating the high efficiency of the system. The system was also found to simultaneously edit two sites, which provides the possibility of treating diseases with multiple mutations Tang et al., 2017) . Almost at the same time, Zhou et al. also conducted base editing tests on human 3PN embryos (Zhou et al., 2017) . Their study used two systems, theBE3 and SaKKH-BE3 systems, to edit three loci of 3PN embryos, and the editing efficiency was found to be up to 52% (Zhou et al., 2017) . In addition, it was found that 3 embryos were 100% edited at the FANCF locus by the SaKKH-BE3 system (Zhou et al., 2017) . In March 2019, Hui Yang's team at the Institute of Neurology of the Chinese Academy of Sciences reported that single-base editing in 2-cell and 4-cell embryos rather than fertilized eggs can effectively improve editing efficiency (Zhou et al., 2017) . Base editing successfully induced homozygous terminator in 2-cell human embryos. The researchers also corrected a heterozygous mutation in the MUT gene with 88% editing frequency (Zhou et al., 2017) . These studies show that gene editing techniques could provide effective ways to correct genetic dysfunction and could be used for disease treatment.
Single-cell spatially resolved transcriptomics
ScRNA-seq technologies have developed rapidly in recent years (Wen and Tang, 2016) . Reproductive biology is the first field in which scRNA-seq has been applied. As mentioned above, a number of scRNA-seq studies have been conducted on human preimplantation embryos, FGCs and spermatogenesis (Li et al., 2017c; Wang et al., 2018b; Yan et al., 2013) . However, the scRNA-seq approaches used in these studies have not preserved spatial information. Thus, many questions remain regarding how to couple single-cell transcriptomics with morphological staging during germ cell development. These questions can be addressed by rapidly developing spatially resolved single-cell transcriptome sequencing technologies. A list of current spatially resolved transcriptome sequencing technologies is provided in Table  6 .
RNA tomography sequencing (Tomo-Seq) and in silico spatial transcriptome (iTranscriptome) sequencing combine low-input RNA sequencing with serial cryosectioning to preserve the spatial information of a developing embryo (Junker et al., 2014; Peng et al., 2016) . Using these methods, complex 3D spatial transcriptomes have been reconstructed for somite-stage zebrafish embryos and mid-streak-stage mouse embryos. Spatial transcriptomics technology applies glass slides with immobilized reverse transcription oligo (dT) primers to capture the two-dimensional spatial transcriptome information of tissue sections (Stahl et al., 2016) . This method has been successfully used for brain and cancer tissue sections.
The abovementioned methods are useful, but they do not provide single-cell resolution. The transcriptome in vivo analysis (TIVA) approach uses a photoactive tagging strategy for capturing mRNA from single cells in live tissue (Lovatt et al., 2014) . Sequential fluorescence in situ hy-bridization (SeqFISH) and multiplexed error-robust fluorescence in situ hybridization (MERFISH) technologies are based on single-molecule fluorescence in situ hybridization (smFISH) Lubeck et al., 2014; Shah et al., 2016) . SeqFISH uses a temporal combinatorial barcoding approach. For a given transcript, a limited set of fluorophores is used, and the transcript is barcoded by sequential probe hybridization (Lubeck et al., 2014; Shah et al., 2016) . MERFISH uses temporal combinatorial barcoding with a two-step labeling approach. The encoding probes are composed of a RNA-targeting sequence and two flanking readout sequences, which are designed for targeting hybridization followed by readout hybridization . MERFISH applies a modified Hamming code for correction of errors in the temporal barcode. Three in situ-based sequencing methods, including targeted in situ sequencing (ISS), fluorescence in situ sequencing (FISSEQ) and spatially-resolved transcript amplicon readout mapping (STARmap), have been reported (Ke et al., 2013; Lee et al., 2014a; Wang et al., 2018c) . These methods use rolling-circle amplification (RCA) to amplify the signal, and the product is then subjected to sequencing-by-ligation methods. STARmap, in particular, uses a specific amplification of nucleic acids via intramolecular ligation (SNAIL) approach to omit the reverse transcription step, thus increasing efficiency (Wang et al., 2018c) .
Conclusion
In summary, scientific research on reproductive biology has been greatly prompted by the advancement of novel technologies. In particular, transcriptome and epigenome sequencing technologies of single-cell or small number of cells have facilitated the identification of novel cell types and 
STARmap
Spatially resolved transcript amplicon readout mapping In situ RNA sequencing Yes (Wang et al., 2018c) states, and dynamic gene expression and epigenetic modifications of mammalian germline cell development and human infertility. In the future, we expect that the continuing development of the single-cell sequencing and gene editing technologies and their applications to the field will enable comprehensive and deep understanding of multiple omic layers of germ cell development and diseases, which will eventually lead to better diagnosis and therapy approaches for human infertility.
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